1
|
Bestel J, Pressnitzer D, Robier M, Rembaud F, Renard C, Leclercq F, Vincent C. Reference data for a quick speech-in-noise hearing test in the French language. Audiol Neurootol 2024:000537768. [PMID: 38498993 DOI: 10.1159/000537768] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2023] [Accepted: 02/07/2024] [Indexed: 03/20/2024] Open
Abstract
INTRODUCTION Difficulties in understanding speech in noise is the most common complaint of people with hearing impairment. Thus, there is a need for tests of speech-in-noise ability in clinical settings, which have to be evaluated for each language. Here, a reference dataset is presented for a quick speech-in-noise test in the French language (Vocale Rapide dans le Bruit, VRB; Leclercq, Renard & Vincent, 2018). METHODS A large cohort (N=641) was tested in a nationwide multicentric study. The cohort comprised normal-hearing individuals and individuals with a broad range of symmetrical hearing losses. Short everyday sentences embedded in babble noise were presented over a spatial array of loudspeakers. Speech level was kept constant while noise level was progressively increased over a range of signal-to-noise ratios. The signal-to-noise ratio for which 50% of keywords could be correctly reported (Speech Reception Threshold, SRT) was derived from psychometric functions. Other audiometric measures were collected for the cohort, such as audiograms and speech-in-quiet performance. RESULTS The VRB test was both sensitive and reliable, as shown by the steep slope of the psychometric functions and by the high test-retest consistency across sentence lists. Correlation analyses showed that pure tone averages derived from the audiograms explained 74% of the SRT variance over the whole cohort, but only 29% for individuals with clinically normal audiograms. SRTs were then compared to recent guidelines from the French Society of Audiology (Joly et al., 2021). Among individuals who would not have qualified for hearing aid prescription based on their audiogram or speech intelligibility in quiet, 18.4% were now eligible as they displayed SRTs in noise impaired by 3 dB or more. For individuals with borderline audiograms, between 20 dB HL and 30 dB HL, the prevalence of impaired SRTs increased to 71.4%. Finally, even though five lists are recommended for clinical use, a minute-long screening using only one VRB list detected 98.6% of impaired SRTs. CONCLUSION The reference data suggest that VRB testing can be used to identify individuals with speech-in-noise impairment.
Collapse
|
2
|
Abstract
OBJECTIVE The decline in suicide rates has leveled off in many countries during the last decade, suggesting that new interventions are needed in the work with suicide prevention. Learnings from investigations of suicide should contribute to the development of these new interventions. However, reviews of investigations have indicated that few new lessons have been learned. To be an effective tool, revisions of the current investigation methods are required. This review aimed to describe the problems with the current approaches to investigations of suicide as patient harm and to propose ways to move forward. METHODS Narrative literature review. RESULTS Several weaknesses in the current approaches to investigations were identified. These include failures in embracing patient and system perspectives, not addressing relevant factors, and insufficient competence of the investigation teams. Investigation methods need to encompass the progress of knowledge about suicidal behavior, suicide prevention, and patient safety. CONCLUSIONS There is a need for a paradigm shift in the approaches to investigations of suicide as potential patient harm to enable learning and insights valuable for healthcare improvement. Actions to support this paradigm shift include involvement of patients and families, education for investigators, multidisciplinary analysis teams with competence in and access to relevant parts across organizations, and triage of cases for extensive analyses. A new model for the investigation of suicide that support these actions should facilitate this paradigm shift.HIGHLIGHTSThere are weaknesses in the current approaches to investigations of suicide.A paradigm shift in investigations is needed to contribute to a better understanding of suicide.New knowledge of suicidal behavior, prevention, and patient safety must be applied.
Collapse
|
3
|
Righini C, Laccourreye O, Fakhry N, Franco-Vidal V, Leboulanger N, Lisan Q, Radulesco T, Rumeau C, Schmerber S, Simon F, Thaï Van H, Vergez S, Vincent C, Jankowski R. Writing in the European Annals of Otorhinolaryngology Head & Neck Diseases. Dos and Don'ts! Eur Ann Otorhinolaryngol Head Neck Dis 2024; 141:21-26. [PMID: 37778943 DOI: 10.1016/j.anorl.2023.09.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/03/2023]
Abstract
Too many articles are still rejected by scientific medical journals due to lack of preparation of the manuscript and of knowledge of the modern editorial rules that govern scientific medical writing. Therefore, the editorial board of the European Annals of Otorhinolaryngology Heads & Neck Diseases summarized studies published by its members since 2020 in the columns of the scientific journal of the French Society of Otorhinolaryngology and the International Francophone Society of Otorhinolaryngology and data from the PubMed indexed literature dedicated to scientific medical writing in otolaryngology in the 21st century. The authors hope that this review, in the form of a list of "Dos and Don'ts", will provide authors with a practical guide facilitating publication of rigorous, reproducible and transparent scientific studies, in accordance with the movement toward better science that society as a whole has been fighting for since the beginning of this century.
Collapse
Affiliation(s)
- C Righini
- Editorial board, European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, centre hospitalier universitaire, université Grenoble-Alpes, CS 10217, 38043, Grenoble cedex 9, France.
| | - O Laccourreye
- Editorial board, European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, HEGP, AP-HP, université Paris Cité, 20, rue Leblanc, 75015 Paris, France
| | - N Fakhry
- Editorial board, European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, hôpital de La Conception, université Aix-Marseille, 147, boulevard Baille, 13005 Marseille, France
| | - V Franco-Vidal
- Editorial board, European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, hôpital Pellegrin, université de Bordeaux, place Amélie-Raba-Leon, 33000 Bordeaux, France
| | - N Leboulanger
- Editorial board, European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, hôpital Necker enfants-malades, AP-HP, université Paris Cité, 149, rue de Sèvres, 75015 Paris, France
| | - Q Lisan
- Editorial board, European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, hôpital Foch, 40, rue Worth, 92150 Suresnes, France
| | - T Radulesco
- Editorial board, European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, hôpital de La Conception, université Aix-Marseille, 147, boulevard Baille, 13005 Marseille, France
| | - C Rumeau
- Editorial board, European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, hôpitaux de Brabois, université de Lorraine, rue du Morvan, 54511 Vandoeuvre-les-Nancy, France
| | - S Schmerber
- Editorial board, European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, centre hospitalier universitaire, université Grenoble-Alpes, CS 10217, 38043, Grenoble cedex 9, France
| | - F Simon
- Editorial board, European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, hôpital Necker enfants-malades, AP-HP, université Paris Cité, 149, rue de Sèvres, 75015 Paris, France
| | - H Thaï Van
- Editorial board, European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'audiologie et d'explorations otoneurologiques, hôpital Edouard-Herriot, hospices civils de Lyon, 69003 Lyon, France; Université Claude-Bernard Lyon 1, 69100 Villeurbanne, France
| | - S Vergez
- Editorial board, European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, hôpital Larrey, université de Toulouse, 24, chemin de Pouvourville, 31400 Toulouse, France
| | - C Vincent
- Editorial board, European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, hôpital Roger-Salengro, université de Lille, avenue du Professeur Emile-Laine, 59037 Lille, France
| | - R Jankowski
- Editorial board, European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, hôpitaux de Brabois, université de Lorraine, rue du Morvan, 54511 Vandoeuvre-les-Nancy, France
| |
Collapse
|
4
|
Routledge M, Lyon J, Vincent C, Gordon Clarke A, Shawcross K, Turpin C, Cormack H, Robson SC, Beckett A, Glaysher S, Cook K, Fearn C, Goudarzi S, Hutley EJ, Ross D. Management of a large outbreak of COVID-19 at a British Army training centre: lessons for the future. BMJ Mil Health 2023; 169:488-492. [PMID: 34772689 PMCID: PMC8594976 DOI: 10.1136/bmjmilitary-2021-001976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Accepted: 10/07/2021] [Indexed: 11/04/2022]
Abstract
INTRODUCTION The COVID-19 pandemic has posed major challenges for infection control within training centres, both civilian and military. Here we present a narrative review of an outbreak that occurred at the Royal Military Academy Sandhurst (RMAS) in January-March 2021, in the context of the circulating, highly transmissible SARS-CoV-2 variant B.1.1.7. METHODS Testing for SARS-CoV-2 was performed using a combination of reverse transcriptase PCR and Lateral Flow Devices (LFDs). Testing and isolation procedures were conducted in line with a pre-established symptom stratification system. Genomic sequencing was performed on 10 sample isolates. RESULTS By the end of the outbreak, 185 cases (153 Officer Cadets, 32 permanent staff) had contracted confirmed COVID-19. This represented 15% of the total RMAS population. This resulted in 0 deaths and 0 hospitalisations, but due to necessary isolation procedures did represent an estimated 12 959 person-days of lost training. 9 of 10 (90%) of sequenced isolates had a reportable lineage. All of those reported were found to be the Alpha lineage B.1.1.7. CONCLUSIONS We discuss the key lessons learnt from the after-action review by the Incident Management Team. These include the importance of multidisciplinary working, the utility of sync matrices to monitor outbreaks in real time, issues around Officer Cadets reporting symptoms, timing of high-risk training activities, infrastructure and use of LFDs. COVID-19 represents a vital learning opportunity to minimise the impact of potential future pandemics, which may produce considerably higher morbidity and mortality in military populations.
Collapse
Affiliation(s)
- Matthew Routledge
- Defence Pathology, Royal Centre for Defence Medicine, Birmingham, UK
- Medical Officer, 254 Medical Regiment, Cambridge, UK
| | - J Lyon
- Senior Medical Officer, Royal Military Academy Sandhurst, Camberley, UK
| | - C Vincent
- Medical Planner, HQ Army Recruiting and Initial Training Command, Pewsey, UK
| | - A Gordon Clarke
- XO, HQ Army Recruiting and Initial Training Command, Pewsey, UK
| | - K Shawcross
- Environmental Health, Medical Branch, Head Quarters Regional Command, Aldershot, UK
| | - C Turpin
- ACOS, Royal Military Academy Sandhurst, Camberley, UK
| | - H Cormack
- Chief of Staff, HQ Army Recruiting and Initial Training Command, Pewsey, UK
| | - S C Robson
- School of Pharmacy & Biomedical Science, University of Portsmouth, Portsmouth, UK
- Centre for Enzyme Innovation, University of Portsmouth, Portsmouth, UK
- School of Biological Sciences, University of Portsmouth, Portsmouth, UK
| | - A Beckett
- Centre for Enzyme Innovation, University of Portsmouth, Portsmouth, UK
| | - S Glaysher
- Research & Innovation, Queen Alexandra Hospital, Portsmouth Hospitals University NHS Trust, Portsmouth, UK
| | - K Cook
- School of Pharmacy & Biomedical Science, University of Portsmouth, Portsmouth, UK
| | - C Fearn
- School of Pharmacy & Biomedical Science, University of Portsmouth, Portsmouth, UK
| | - S Goudarzi
- School of Pharmacy & Biomedical Science, University of Portsmouth, Portsmouth, UK
| | - E J Hutley
- Defence Pathology, Royal Centre for Defence Medicine, Birmingham, UK
| | - D Ross
- Parkes Professor, Army Medical Services, Camberley, UK
| |
Collapse
|
5
|
Thai-Van H, Mosnier I, Dejean F, Ambert-Dahan E, Bakhos D, Belmin J, Bonnard D, Borel S, Ceccato JC, Coez A, Damien M, Del Rio M, El Yagoubi M, Genin A, Gros A, Harichaux M, Idriss S, Ionescu E, Joly CA, Salmon PK, Marianowski R, Marx M, Mom T, Parietti-Winkler C, Potier M, Renard C, Roman S, Roy T, Tronche S, Venail F, Vincent C, Reynard P. Early management of presbycusis: recommendations from the French Society of Otorhinolaryngology and Head and Neck Surgery, the French Society of Audiology, and the French Society of Geriatrics and Gerontology. Geriatr Psychol Neuropsychiatr Vieil 2023:1-11. [PMID: 37170803 DOI: 10.1684/pnv.2023.1094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
INTRODUCTION Presbycusis is the physiological decrease in hearing due to advancing age and begins well before the sixth decade. These recommendations recall the principles of early diagnosis of presbycusis and the means of optimal rehabilitation as soon as the first symptoms appear. MATERIAL AND METHODS The recommendations are based on a systematic analysis of the literature carried out by a multidisciplinary group of ENT physicians, audiologists, geriatricians and hearing specialists from all over France. They are classified as grade A, B, C or professional agreement according to a decreasing level of scientific evidence. RESULTS The diagnosis of presbycusis is more difficult at the beginning of its evolution but a certain number of tools are available for its early diagnosis and its face-to-face or remote management. CONCLUSION In the case of a clinical profile suggestive of presbycusis in a young subject, especially if there are several family cases, it is recommended to propose a genetic investigation. Free-field speech audiometry in noise is recommended to measure intelligibility in a realistic environment. Questionnaires in addition to audiometric tests would allow the best assessment of the patient's disability. Hearing rehabilitation with a hearing aid or cochlear implant may slow or prevent cognitive decline. Combined auditory and cognitive rehabilitation should be offered regardless of the time since the hearing was fitting. It is recommended to integrate programs accessible via smartphones, tablets or the Internet, that include different training domains to complement face-to-face sessions.
Collapse
Affiliation(s)
- Hung Thai-Van
- Service d'audiologie et d'explorations otoneurologiques, CHU de Lyon, Hôpital Édouard-Herriot, Lyon, France, Claude-Bernard University Lyon 1, Institut de l'audition, Institut Pasteur, Inserm, Paris, France
| | - Isabelle Mosnier
- Institut de l'audition, Institut Pasteur, Inserm, Paris, France, ORL Department, Ile de France reference centre for cochlear and brainstem implants in adults, Pitié-Salpêtrière Hospital Group, Sorbonne University, AP -HP, Paris, France
| | | | - Emmanuelle Ambert-Dahan
- ORL Department, Ile de France reference centre for cochlear and brainstem implants in adults, Pitié-Salpêtrière Hospital Group, Sorbonne University, AP -HP, Paris, France
| | - David Bakhos
- ENT Department, CHU de Tours, iBrain, Inserm U1253, Université François- Rabelais, Tours, France
| | - Joël Belmin
- AP-HP, University Hospitals Pitié- Salpêtrière - Charles-Foix, Department of Geriatrics with a cardiological and neurological orientation, Ivry-sur-Seine, Sorbonne University, Paris, France
| | | | - Stéphanie Borel
- ORL Department, Ile de France reference centre for cochlear and brainstem implants in adults, Pitié-Salpêtrière Hospital Group, Sorbonne University, AP -HP, Paris, France
| | - Jean-Charles Ceccato
- Institute for Neurosciences of Montpellier, Inserm U1298, Centre de recherche et de formation en audioprothèse, University of Montpellier, Montpellier, France
| | - Arnaud Coez
- Institut de l'audition, Institut Pasteur, Inserm, Paris, France
| | - Maxime Damien
- Service d'audiologie et d'explorations otoneurologiques, CHU de Lyon, Hôpital Édouard-Herriot, Lyon, France, Claude-Bernard University Lyon 1, Institut de l'audition, Institut Pasteur, Inserm, Paris, France
| | | | | | | | - Auriane Gros
- ORL Department, Centre mémoire ressources et recherche, CHU de Nice, Institut Claude-Pompidou, Nice, France
| | | | - Samar Idriss
- Service d'audiologie et d'explorations otoneurologiques, CHU de Lyon, Hôpital Édouard-Herriot, Lyon, France
| | - Eugen Ionescu
- Service d'audiologie et d'explorations otoneurologiques, CHU de Lyon, Hôpital Édouard-Herriot, Lyon, France, Institut de l'audition, Institut Pasteur, Inserm, Paris, France
| | - Charles-Alexandre Joly
- Service d'audiologie et d'explorations otoneurologiques, CHU de Lyon, Hôpital Édouard-Herriot, Lyon, France, Institut de l'audition, Institut Pasteur, Inserm, Paris, France
| | | | - Rémi Marianowski
- ORL Department, CHU de Brest, Laboratoire de neurobiologie, UA 4685, Brest, France
| | - Mathieu Marx
- Department of Otology and Otoneurology, Hôpital Pierre-Paul-Riquet, CHU Toulouse Purpan, Toulouse, France
| | - Thierry Mom
- ORL Department, CHU d'Estaing, Clermont-Ferrand, France
| | | | | | - Christian Renard
- Department of Otology and Otoneurology, Salengro Hospital, University of Lille, Lille, France
| | - Stéphane Roman
- ORL Department, Hôpital de la Timone et de la Conception, Marseille, France
| | | | | | - Frédéric Venail
- Otology and Otoneurology unit, ORL Department, CHU Gui-de-Chauliac, Montpellier, France
| | - Christophe Vincent
- Department of Otology and Otoneurology, Salengro Hospital, University of Lille, Lille, France
| | - Pierre Reynard
- Service d'audiologie et d'explorations otoneurologiques, CHU de Lyon, Hôpital Édouard-Herriot, Lyon, France, Claude-Bernard University Lyon 1, Institut de l'audition, Institut Pasteur, Inserm, Paris, France
| |
Collapse
|
6
|
Cassagnaud P, Deneve A, Zielinski N, Vincent C, Renard C, Pasquier F, Moroni C. Projet COG-AUDIO : évaluation des troubles de la compréhension de la parole dans le bruit au centre mémoire ressources recherche (CMRR) du CHU de Lille. Rev Neurol (Paris) 2023. [DOI: 10.1016/j.neurol.2023.01.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/29/2023]
|
7
|
Plagiannakos CG, Montano-Loza AJ, Lytvyak E, Pallotta J, Mason AL, Qumosani KM, Worobetz L, Flemming JA, Hercun J, Vincent C, Cheung A, Chen T, Grbic D, Swain MG, Gulamhusein A, Hansen BE, Hirschfield GM. A44 A 1000 PATIENT CANADIAN NETWORK FOR AUTOIMMUNE LIVER DISEASE EVALUATION OF CLINICAL AND DEMOGRAPHIC PATTERNS OF AUTOIMMUNE HEPATITIS. J Can Assoc Gastroenterol 2023. [PMCID: PMC9991181 DOI: 10.1093/jcag/gwac036.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/09/2023] Open
Abstract
Background We sought to understand how the demographics of autoimmune hepatitis (AIH) have changed over time in Canada. Purpose Using a large multi-centre Canadian cohort of patients with AIH, we describe the trends in patient and disease characteristics at presentation across 30 years of clinical practice. Method Patients from the Canadian Network for Autoimmune Liver Disease with a confirmed diagnosis of AIH (simplified score ≥6) were included for analysis. Patients were grouped into five cohorts according to the year of diagnosis (i.e., <2000, 2000-2004, 2005-2009, 2010-2014, ≥2015). Patient demographics and baseline clinical and biochemistry features of disease activity were investigated using Chi-square tests and Kruskal-Wallis tests adjusted for multiple comparisons. Logistic and linear regression models with estimated means were utilized to further investigate relationships with time and to adjust for confounding. Result(s) 1016 patients followed across 10 Canadian health centres with AIH were diagnosed between November 1965 and December 2021. Overall, 76.4% (n=776) of patients were female, and the median age at diagnosis was 46 years (IQR 28.2 - 58.3). Cirrhosis at presentation was seen in 20.6% of patients (n=209). The median age at diagnosis increased significantly from 31.8 years [IQR 17.9 - 46.8] pre-2000 to 54 years [IQR 9.0 - 95.2] after 2014 (p<0.001; Figure 1a). This effect of time persisted after adjusting for sex and cirrhosis status at diagnosis. Female sex and the presence of cirrhosis at diagnosis were factors independently associated with older age at presentation (p<0.0001). The proportion of patients that presented with cirrhosis at diagnosis increased significantly over calendar time, from 13.7% (n=23) pre-2000 to 30.8% (n=69) after 2014 (p=0.003; Figure 1b). Male sex was independently associated with an increased odds of having cirrhosis at presentation (OR= 1.46, CI 1.02 - 2.07) and higher baseline ALT levels compared to females (p=0.036). The proportion of patients that identified as non-white ethnicity increased significantly from 15.2% (n= 24) pre-2000, to 32% (n= 86) after 2014 (p<0.001, Figure 1b). This effect of time on ethnicity was most pronounced after the year 2010 (OR= 2.32, CI 1.39 - 3.98) and persisted after adjusting for sex. There was no significant pattern of change in sex over calendar time. Image ![]()
Conclusion(s) In Canada, patients with AIH at presentation are now older, have more advanced disease, and are more ethnically diverse than when compared to 30 years ago. Please acknowledge all funding agencies by checking the applicable boxes below Other Please indicate your source of funding; industry Disclosure of Interest None Declared
Collapse
Affiliation(s)
- C G Plagiannakos
- Toronto Centre for Liver Disease, Toronto Western and General Hospital, University Health Network,Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto
| | - A J Montano-Loza
- Division of Gastroenterology and Hepatology, University of Alberta, Edmonton
| | - E Lytvyak
- Division of Gastroenterology and Hepatology, University of Alberta, Edmonton
| | - J Pallotta
- Toronto Centre for Liver Disease, Toronto Western and General Hospital, University Health Network
| | - A L Mason
- Division of Gastroenterology and Hepatology, University of Alberta, Edmonton
| | - K M Qumosani
- Department of Medicine, Western University, London
| | - L Worobetz
- Department of Medicine, University of Saskatchewan, Saskatoon
| | - J A Flemming
- Medicine and Public Health Sciences, Queen's University, Kingston
| | - J Hercun
- Département De Médecins, Centre Hospitalier De l’Université De Montréal, Montréal
| | - C Vincent
- Département De Médecins, Centre Hospitalier De l’Université De Montréal, Montréal
| | - A Cheung
- Department of Medicine, University of Ottawa, Ottawa
| | - T Chen
- Department of Medicine, McGill University Health Centre, Montréal
| | - D Grbic
- Université De Sherbrooke, Sherbrooke
| | - M G Swain
- Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Canada
| | - A Gulamhusein
- Toronto Centre for Liver Disease, Toronto Western and General Hospital, University Health Network,Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto
| | - B E Hansen
- Toronto Centre for Liver Disease, Toronto Western and General Hospital, University Health Network,Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto,Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands
| | - G M Hirschfield
- Toronto Centre for Liver Disease, Toronto Western and General Hospital, University Health Network,Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto
| |
Collapse
|
8
|
Coman DE, Vincent C, Lavoie A, Bilodeau M, Hercun J. A82 PREVALENCE AND NON-INVASIVE SCREENING FOR CYSTIC FIBROSIS RELATED LIVER DISEASE IN A COHORT FOLLOWED AT A CYSTIC FIBROSIS REFERENCE CENTER. J Can Assoc Gastroenterol 2023. [PMCID: PMC9991356 DOI: 10.1093/jcag/gwac036.082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/09/2023] Open
Abstract
Background The reported prevalence of cystic fibrosis (CF) related liver disease (CFLD) varies widely based on diagnostic criteria but reaches up to 40% in some cohorts. Furthermore, its clinical impact is significant as hepatic involvement is the 3rd leading cause of mortality in CF patients and is associated with a lower life expectancy. Due to the heterogeneous clinical presentation of CFLD, clear diagnostic criteria and non-invasive assessment methods are lacking. Purpose This study aimed to measure the prevalence of CFLD in a cohort of patients followed at a tertiary CF center. Method The files of all patients followed at the CF clinic of the Centre hospitalier de l’Université de Montréal in 2021 were retrospectively reviewed. Imaging reports, histopathology, laboratory values and transient elastography results were assessed. The NIH criteria were used to define CFLD through either presence of one major criteria (abnormal imaging) or two minor criteria (persistently abnormal lab values, hepatosplenomegaly, or transient elastography ≥ 7 kPa). Result(s) 358 patients were included in our study, 56% male with a median age of 36 years. While mean liver tests were within normal limits (ALT 24 U/L, AST 26 U/L, ALP 96 U/L, GGT 29 U/L), 182 patients (51%) had at least one episode of abnormal liver function tests (LFTs), and 85 patients (24%) had persistently abnormal LFTs. CFLD was present in 42 patients (12%), with 39 patients presenting major criteria and 3 patients presenting minor criteria. In addition, 67 patients (19%) had solely hepatic steatosis. Furthermore, clinically significant portal hypertension and esophageal varices were detected in 50% of patients with CFLD who underwent upper endoscopy (n=20). Median transient elastography value was 5.4 kPa (interquartile range 4.25 kPa) in the 51 patients with exam results, and 32% had values ≥ 7 kPa. Fibroscan values correlated well with the presence of major criteria, with an area under the curve (AUROC) of 0.80 (0.68-0.92, p=0.0007), while non-invasive serological markers did not perform as well (Fib4: AUROC 0.70 (0.59-0.81) and APRI: AUROC 0.69 (0.59-0.80)). Conclusion(s) The overall prevalence of CFLD, including hepatic steatosis, was 31% in this cohort. Prompt recognition is important in clinical care in order to prevent hepatic complications from cirrhosis and portal hypertension. The use of Fibroscan seems promising for detecting CFLD. Please acknowledge all funding agencies by checking the applicable boxes below None Disclosure of Interest None Declared
Collapse
Affiliation(s)
- D E Coman
- Internal Medicine, CHUM,Université de Montréal
| | | | | | | | - J Hercun
- Hepatology,Université de Montréal, Montréal, Canada
| |
Collapse
|
9
|
Nagendra A, Orleans-Pobee M, Vincent C, Padgett J, Merritt C, Crosby C, Welch K, Roberts SO, Penn DL. The representation of authors of color in schizophrenia research articles published in high-impact psychiatric journals. Schizophr Res 2023; 253:75-78. [PMID: 36216712 DOI: 10.1016/j.schres.2022.08.021] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/24/2022] [Revised: 07/06/2022] [Accepted: 08/23/2022] [Indexed: 11/16/2022]
Abstract
OBJECTIVE We evaluate how often scholars of color publish papers on schizophrenia in high-impact psychiatric journals, and whether they are more likely than white authors to prioritize race/ethnicity as a primary variable of interest in analyses. METHODS Prior work categorized the types of ethnoracial analyses reported in 474 papers about schizophrenia published in high-impact psychiatric journals between 2014 and 2016. In this study, the photographs of the first and last author for each paper were coded as "person of color" (POC) or "white". Additionally, each author was asked to self-report their race and ethnicity. The percentage of papers published by white versus POC authors was calculated. Chi-square analyses tested the hypotheses that (a) white scholars are more likely than POC scholars to conduct any sort of racial analysis; (b) POC scholars are more likely to conduct primary analyses by race/ethnicity; and (c) white scholars are more likely to analyze race/ethnicity as extraneous variables. RESULTS Eighteen percent of papers were published by POC first authors, and 17% were published by POC last authors. There were minimal differences in the types of analyses conducted by POC and white authors. Self-reported race/ethnicity showed that Asian scholars were the most highly represented within POC authors (9% of respondents), but only 3% of authors identified as Hispanic/Latinx and none identified as Black or Indigenous American. CONCLUSIONS People of color are underrepresented as authors in US-based schizophrenia research published in high-impact journals. Culturally-informed mentorship as well as prioritization of race/ethnicity in funding structures are important to increase representation of POC authors.
Collapse
Affiliation(s)
- A Nagendra
- Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
| | - M Orleans-Pobee
- Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - C Vincent
- Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - J Padgett
- Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - C Merritt
- Department of Psychology, Center for Comparative Studies in Race and Ethnicity, Stanford University, USA
| | - C Crosby
- Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - K Welch
- Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - S O Roberts
- Department of Psychology, Center for Comparative Studies in Race and Ethnicity, Stanford University, USA
| | - D L Penn
- Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Australian Catholic University, School of Behavioural and Health Sciences, Melbourne, VIC, Australia
| |
Collapse
|
10
|
Reynard P, Mosnier I, Dejean F, Ambert-Dahan E, Bakhos D, Belmin J, Bonnard D, Borel S, Ceccato JC, Coez A, Damien M, Del Rio M, El Yagoubi M, Genin A, Gros A, Harichaux M, Idriss S, Ionescu E, Joly CA, Krolak-Salmon P, Marianowski R, Marx M, Mom T, Parietti-Winkler C, Potier M, Renard C, Roman S, Roy T, Tronche S, Venail F, Vincent C, Thai-Van H. [Early management of presbycusis: recommendations from the French Society of Otorhinolaryngology and Head and Neck Surgery, the French Society of Audiology, and the French Society of Geriatrics and Gerontology]. Geriatr Psychol Neuropsychiatr Vieil 2023; 21:9-20. [PMID: 37115675 DOI: 10.1684/pnv.2023.1090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/29/2023]
Abstract
INTRODUCTION Presbycusis is the physiological decrease in hearing due to advancing age and begins well before the sixth decade. These recommendations recall the principles of early diagnosis of presbycusis and the means of optimal rehabilitation as soon as the first symptoms appear. MATERIAL AND METHODS The recommendations are based on a systematic analysis of the literature carried out by a multidisciplinary group of doctors and audioprosthetists from all over France. They are graded A, B, C or expert opinion according to decreasing level of scientific evidence. RESULTS The diagnosis of presbycusis is more difficult at the beginning of its evolution but a certain number of tools are available for its early diagnosis and its management in face-to-face or even distance learning. CONCLUSION In case of a clinical profile suggestive of presbycusis in a young subject, especially if there are several family cases, it is recommended to propose a genetic investigation. It is recommended to perform free-field speech audiometry in noise to measure intelligibility in an environment as close as possible to reality. Questionnaires can be used in addition to audiometry to best assess the patient's disability. It is recommended that hearing rehabilitation with a hearing aid or cochlear implant may slow or prevent cognitive decline. Combined auditory and cognitive rehabilitation should be offered regardless of the time elapsed since the fitting. It is recommended to integrate programs accessible via smartphones, tablets or the Internet, integrating different training domains in addition to face-to-face sessions.
Collapse
Affiliation(s)
- Pierre Reynard
- Service d'audiologie et d'explorations otoneurologiques, CHU de Lyon, Hôpital Édouard Herriot, Lyon, France, Université Lyon 1, Institut de l'audition, Institut Pasteur, Inserm, Paris, France
| | - Isabelle Mosnier
- Institut de l'audition, Institut Pasteur, Inserm, Paris, France, APHP-Sorbonne Université, GH Pitié-Salpêtrière, service ORL, unité fonctionnelle implants auditifs, Paris, France
| | | | - Emmanuelle Ambert-Dahan
- APHP-Sorbonne Université, GH Pitié-Salpêtrière, service ORL, unité fonctionnelle implants auditifs, Paris, France
| | - David Bakhos
- Service ORL, CHU de Tours, Inserm UMR 1253 I-Brain, Université François-Rabelais, Tours, France
| | - Joël Belmin
- AP-HP, Hôpitaux universitaires Pitie-Salpêtrière-Charles Foix, Service de Gériatrie à orientation Cardiologique et Neurologique, F-94200 Ivry-sur-Seine, Sorbonne Université, Paris, France
| | - Damien Bonnard
- Service ORL, CHU de Bordeaux, Hôpital Pellegrin, Bordeaux, France
| | - Stéphanie Borel
- APHP-Sorbonne Université, GH Pitié-Salpêtrière, service ORL, unité fonctionnelle implants auditifs, Paris, France
| | - Jean-Charles Ceccato
- Institut des Neurosciences de Montpellier - Inserm U1298, Centre de Recherche et de Formation en Audioprothèse - Montpellier, France
| | - Arnaud Coez
- Institut de l'audition, Institut Pasteur, Inserm, Paris, France
| | - Maxime Damien
- Service d'audiologie et d'explorations otoneurologiques, CHU de Lyon, Hôpital Édouard Herriot, Lyon, France, Université Lyon 1, Institut de l'audition, Institut Pasteur, Inserm, Paris, France
| | | | | | | | - Auriane Gros
- Service ORL, Centre Mémoire Ressources et Recherche. CHU de Nice, Institut Claude Pompidou, Nice, France
| | | | - Samar Idriss
- Service d'audiologie et d'explorations otoneurologiques, CHU de Lyon, Hôpital Édouard Herriot, Lyon, France
| | - Eugen Ionescu
- Service d'audiologie et d'explorations otoneurologiques, CHU de Lyon, Hôpital Édouard Herriot, Lyon, France, Institut de l'audition, Institut Pasteur, Inserm, Paris, France
| | - Charles-Alexandre Joly
- Service d'audiologie et d'explorations otoneurologiques, CHU de Lyon, Hôpital Édouard Herriot, Lyon, France, Institut de l'audition, Institut Pasteur, Inserm, Paris, France
| | | | - Rémi Marianowski
- Service ORL, CHU de Brest, Laboratoire de Neurobiologie UA 4685, France
| | - Mathieu Marx
- Service d'Otologie, Otoneurologie et ORL pédiatrique, Hôpital Pierre-Paul Riquet, CHU Toulouse Purpan, Toulouse, France
| | - Thierry Mom
- Service ORL, CHU d'Estaing, Clermont-Ferrand, France
| | | | | | - Christian Renard
- Service d'Otologie et d'Otoneurologie, Hôpital Salengro, CHU Lille, Université de Lille, Lille, France
| | - Stéphane Roman
- Service ORL, Hôpital de la Timone et de la Conception, Marseille, France
| | - Thomas Roy
- Société Française d'Audiologie, Paris, France
| | - Sophie Tronche
- Société Française d'Otorhinolaryngologie et de Chirurgie de la Face et du Cou, Paris, France
| | - Frédéric Venail
- Unité Otologie et Otoneurologie, Service ORL, CHU Gui de Chauliac, Montpellier, France
| | - Christophe Vincent
- Service d'Otologie et d'Otoneurologie, Hôpital Salengro, CHU Lille, Université de Lille, Lille, France
| | - Hung Thai-Van
- Service d'audiologie et d'explorations otoneurologiques, CHU de Lyon, Hôpital Édouard Herriot, Lyon, France, Université Lyon 1, Institut de l'audition, Institut Pasteur, Inserm, Paris, France
| |
Collapse
|
11
|
Proulx CE, Higgins J, Vincent C, Vaughan T, Hewko M, Gagnon DH. User-centered development process of an operating interface to couple a robotic glove with a virtual environment to optimize hand rehabilitation following a stroke. J Rehabil Assist Technol Eng 2023; 10:20556683231166574. [PMID: 37077202 PMCID: PMC10107379 DOI: 10.1177/20556683231166574] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2022] [Accepted: 03/14/2023] [Indexed: 04/21/2023] Open
Abstract
Introduction Task-specific neurorehabilitation is crucial to optimize hand recovery shortly after a stroke, but intensive neurorehabilitation remains limited in resource-constrained healthcare systems. This has led to a growing interest in the use of robotic gloves as an adjunct intervention to intensify hand-specific neurorehabilitation. This study aims to develop and assess the usability of an operating interface supporting such a technology coupled with a virtual environment through a user-centered design approach. Methods Fourteen participants with hand hemiparesis following a stroke were invited to don the robotic glove before browsing through the operating interface and its functionalities, and perform two mobility exercises in a virtual environment. Feedback was collected for improving technology usability. Participants completed the System Usability Scale and ABILHAND questionnaires and their recommendations were gathered and prioritized in a Pugh Matrix. Results The System Usability Scale (SUS) score for the operating interface was excellent (M = 87.0 SD = 11.6). A total of 74 recommendations to improve the user interface, calibration process, and exercise usability were identified. Conclusion The application of a full cycle of user-centred design approach confirms the high level of usability of the system which is perceived by end users as acceptable and useful for intensifying neurorehabilitation.
Collapse
Affiliation(s)
- CE Proulx
- School of Rehabilitation, Faculty
of Medicine, Université de Montréal, Montreal, QC, Canada
- Center for Interdisciplinary
Research in Rehabilitation of Greater Montreal, Institut Universitaire sur la
Réadaptation en Déficience Physique de Montréal, CIUSSS
Centre-Sud-de-l’Île-de-Montréal, Montreal, QC, Canada
| | - J Higgins
- School of Rehabilitation, Faculty
of Medicine, Université de Montréal, Montreal, QC, Canada
- Center for Interdisciplinary
Research in Rehabilitation of Greater Montreal, Institut Universitaire sur la
Réadaptation en Déficience Physique de Montréal, CIUSSS
Centre-Sud-de-l’Île-de-Montréal, Montreal, QC, Canada
| | - C Vincent
- Department of Rehabilitation, Université Laval, Quebec, QC, Canada
- Center for Interdisciplinary
Research in Rehabilitation and Social Integration, Centre Intégré Universitaire de Santé
et de Services Sociaux de la Capitale-Nationale, Quebec, QC, Canada
| | - T Vaughan
- Simulation and Digital Health,
Medical Devices Research Centre, National Research Council
Canada, Boucherville, QC, Canada
| | - M Hewko
- Simulation and Digital Health,
Medical Devices Research Centre, National Research Council Canada,
Winnipeg, Winnipeg, MB, Canada
| | - DH Gagnon
- School of Rehabilitation, Faculty
of Medicine, Université de Montréal, Montreal, QC, Canada
- Center for Interdisciplinary
Research in Rehabilitation of Greater Montreal, Institut Universitaire sur la
Réadaptation en Déficience Physique de Montréal, CIUSSS
Centre-Sud-de-l’Île-de-Montréal, Montreal, QC, Canada
- DH Gagnon, School of Rehabilitation,
Université de Montréal-Pavillon Ave du Parc, C.P. 6128, succursale Centre-Ville,
Montreal, QC H3C 3J7, Canada.
| |
Collapse
|
12
|
Rongthong T, Qnouch A, Maue Gehrke M, Paccou L, Oliveira P, Danede F, Verin J, Vincent C, Willart JF, Siepmann F, Siepmann J. Silicone matrices for controlled dexamethasone release: toward a better understanding of the underlying mass transport mechanisms. Regen Biomater 2023; 10:rbad008. [PMID: 36911146 PMCID: PMC9998079 DOI: 10.1093/rb/rbad008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2022] [Revised: 01/25/2023] [Accepted: 02/02/2023] [Indexed: 02/09/2023] Open
Abstract
Dexamethasone-loaded silicone matrices offer an interesting potential as innovative drug delivery systems, e.g. for the treatment of inner ear diseases or for pacemakers. Generally, very long drug release periods are targeted: several years/decades. This renders the development and optimization of novel drug products cumbersome: experimental feedback on the impact of the device design is obtained very slowly. A better understanding of the underlying mass transport mechanisms can help facilitating research in this field. A variety of silicone films were prepared in this study, loaded with amorphous or crystalline dexamethasone. Different polymorphic drug forms were investigated, the film thickness was altered and the drug optionally partially/completely exchanged by much more water-soluble dexamethasone 'phosphate'. Drug release studies in artificial perilymph, scanning electron microscopy, optical microscopy, differential scanning calorimetry, X-ray diffraction and Raman imaging were used to elucidate the physical states of the drugs and polymer, and of the systems' structure as well as dynamic changes thereof upon exposure to the release medium. Dexamethasone particles were initially homogeneously distributed throughout the systems. The hydrophobicity of the matrix former very much limits the amounts of water penetrating into the system, resulting in only partial drug dissolution. The mobile drug molecules diffuse out into the surrounding environment, due to concentration gradients. Interestingly, Raman imaging revealed that even very thin silicone layers (<20 µm) can effectively trap the drug for prolonged periods of time. The physical state of the drug (amorphous, crystalline) did not affect the resulting drug release kinetics to a noteworthy extent.
Collapse
Affiliation(s)
| | - Adam Qnouch
- Univ. Lille, INSERM, CHU Lille, U1008, F-59000 Lille, France
| | | | - Laurent Paccou
- Univ. Lille, UMR CNRS 8207, UMET, F-59655 Villeneuve d'Ascq, France
| | - Paulo Oliveira
- Univ. Lille, UMR CNRS 8207, UMET, F-59655 Villeneuve d'Ascq, France
| | - Florence Danede
- Univ. Lille, UMR CNRS 8207, UMET, F-59655 Villeneuve d'Ascq, France
| | - Jeremy Verin
- Univ. Lille, INSERM, CHU Lille, U1008, F-59000 Lille, France
| | | | | | | | | |
Collapse
|
13
|
Laccourreye O, Lisan Q, Vincent C, Righini C, Leboulanger N, Franco-Vidal V, Radulesco T, Rumeau C, Schmerber S, Simon F, Van HT, Vergez S, Fakhry N, Jankowski R. Keys for successful publication in Eur Ann Otorhinolaryngol Head Neck Dis: A STROBE analysis of peer reviews of articles submitted in 2020-2021. Eur Ann Otorhinolaryngol Head Neck Dis 2023; 140:19-24. [PMID: 35637090 DOI: 10.1016/j.anorl.2022.05.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
OBJECTIVE To evaluate reviewing and editorial decision for articles submitted to the European Annals of Otorhinolaryngology Head & Neck Diseases. MATERIALS AND METHODS A retrospective analysis was made of reviewers' comments on 1,133 scientific articles (700 original articles, 96 literature reviews, and 337 case reports), originating from 69 countries, consecutively submitted on-line between January 1st, 2020 and December 31st, 2021. The main objective was to document the acceptance rate and decision time. Accessory objectives were to synthesize the main comments and to screen for correlations between acceptance and the main characteristics of first authors, articles and reviewers' comments. RESULTS In total, 4.1% of submitted articles were accepted. Median decision time differed significantly (P<0.0001), at 1 month in case of refusal and 4 months in case of acceptance. Reviewers mentioned failure to adhere to the journal's authors' guide, to use the appropriate EQUATOR guidelines and to adopt the recommended P<0.005 significance threshold in 94.8%, 54.2%, and 39.9% of cases, respectively. On multivariate analysis, 3 variables significantly impacted acceptance, which increased from 1.3% to 44.6% (P<0.0001) when an appropriate EQUATOR guideline was used and from 0.3% to 57.4% (P<0.0001) when the significance threshold was set at P<0.005, and decreased from 10.5% to 1.1% (P=0.0001) when the article did not originate from a French-speaking country (member of the Francophonie organization). CONCLUSION Adhesion to modern scientific medical writing rules increased acceptance rates for articles in the European Annals of Otorhinolaryngology Head & Neck Diseases. Teaching modern scientific medical writing needs to be enhanced in otorhinolaryngology.
Collapse
Affiliation(s)
- O Laccourreye
- European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, HEGP, université Paris Cité, AP-HP, 20, rue Leblanc, 75015 Paris, France.
| | - Q Lisan
- European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, hôpital Foch, 32, rue Worth, 92150 Suresnes, France
| | - C Vincent
- European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, université de Lille, hôpital Roger-Salengro, avenue du Professeur Emile-Laine, 59037 Lille, France
| | - C Righini
- European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, université Grenoble-Alpes, 1, avenue des Maquis-du-Gresivaudan, 38043 Grenoble, France
| | - N Leboulanger
- European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, université de Paris, hôpital Necker-Enfants-Malades, 149, rue de Sèvres, 75007 Paris, France
| | - V Franco-Vidal
- European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, université de Bordeaux, hôpital Pellegrin, place Amélie-Raba-Leon, 33000 Bordeaux, France
| | - T Radulesco
- European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, université Aix-Marseille, hôpital de La Conception, 147, boulevard Baille, 13005 Marseille, France
| | - C Rumeau
- European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, université de Lorraine, hôpitaux de Brabois, rue du Morvan, 54511 Vandœuvre-les-Nancy, France
| | - S Schmerber
- European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, CHU de Grenoble-Alpes, université Auvergne Rhône Alpes, boulevard de la Chantourne, 38700 La Tronche, France
| | - F Simon
- European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, université de Paris, hôpital Necker-Enfants-Malades, 149, rue de Sèvres, 75007 Paris, France
| | - H T Van
- European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'audiologie et d'explorations otoneurologiques. université Auvergne Rhône Alpes, hospices civils de Lyon, 3, quai des Célestins, 69002 Lyon, France
| | - S Vergez
- European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, université de Toulouse, hôpital Larrey, 24, chemin de Pouvourville, 31400 Toulouse, France
| | - N Fakhry
- European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, université Aix-Marseille, hôpital de La Conception, 147, boulevard Baille, 13005 Marseille, France
| | - R Jankowski
- European Annals of Otohinolaryngology Head & Neck Diseases, Elsevier, 65, rue Camille-Desmoulins, 92130 Issy-les-Moulineaux, France; Service d'otorhinolaryngologie et de chirurgie cervico-faciale, université de Lorraine, hôpitaux de Brabois, rue du Morvan, 54511 Vandœuvre-les-Nancy, France
| |
Collapse
|
14
|
Debowska R, Pasikowska-Piwko M, Zapotoczna M, Vincent C, Ciescinska C, Ostrowska B, Kuranc A, Rogiewicz K, Eris I. 243 Targeting S. aureus biofilm with leave-on emollients containing oligofructants and acetyl heptapeptide-4 complex. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.09.254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
15
|
Rongthong T, Qnouch A, Gehrke MM, Danede F, Willart J, Oliveira P, Paccou L, Tourrel G, Stahl P, Verin J, Toulemonde P, Vincent C, Siepmann F, Siepmann J. Long term behavior of dexamethasone-loaded cochlear implants: In vitro & in vivo. Int J Pharm X 2022; 4:100141. [DOI: 10.1016/j.ijpx.2022.100141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2022] [Revised: 11/17/2022] [Accepted: 11/19/2022] [Indexed: 11/23/2022] Open
|
16
|
Vincent C, Allan S, Naylor G, Stephen R, Bray S, Thornton A, Kirk A. Fission chamber data acquisition system for neutron flux measurements on the Mega-Amp Spherical Tokamak Upgrade. Rev Sci Instrum 2022; 93:093509. [PMID: 36182454 DOI: 10.1063/5.0106725] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/29/2022] [Accepted: 08/15/2022] [Indexed: 06/16/2023]
Abstract
Neutron flux measurements are important in fusion devices for both safety requirements and physics studies. A new system has been built for the Mega-Amp Spherical Tokamak Upgrade (MAST Upgrade) that provides neutron count, DC, and Campbell mode measurements for a 1 µs period at 1 MHz. The acquisition system uses a Red Pitaya board to sample current from two fission chambers mounted on the side of the MAST-U vessel. The system-on-chip design of the Zynq-7020 on the Red Pitaya also allows a web server implementation using Flask for data retrieval and diagnostic configuration over the MAST Upgrade network.
Collapse
Affiliation(s)
- C Vincent
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon, Oxon OX14 3DB, United Kingdom
| | - S Allan
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon, Oxon OX14 3DB, United Kingdom
| | - G Naylor
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon, Oxon OX14 3DB, United Kingdom
| | - R Stephen
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon, Oxon OX14 3DB, United Kingdom
| | - S Bray
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon, Oxon OX14 3DB, United Kingdom
| | - A Thornton
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon, Oxon OX14 3DB, United Kingdom
| | - A Kirk
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon, Oxon OX14 3DB, United Kingdom
| |
Collapse
|
17
|
Toulemonde P, Risoud M, Lemesre P, Tardivel M, Siepmann J, Vincent C. 3D analysis of gerbil cochlea with cochlear implant. Eur Ann Otorhinolaryngol Head Neck Dis 2022; 139:333-336. [DOI: 10.1016/j.anorl.2022.03.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
18
|
Jaiswal A, Holzhey P, Budhiraja S, Paramasivam A, Santhakumaran S, Cöté S, Boie NR, Savundranayagam M, Vincent C, Kröger E, Wittich W. 1011 CONTINUUM OF GERIATRIC CARE FOR OLDER ADULTS WITH DUAL SENSORY LOSS DURING THE COVID-19 PANDEMIC IN CANADA: LESSONS LEARNED. Age Ageing 2022. [PMCID: PMC9384318 DOI: 10.1093/ageing/afac126.051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Introduction Around 1.1 million older Canadians live with combined hearing and vision impairment (dual sensory loss/DSL). Evidence highlights that they are at a high risk of cognitive impairment, functional decline, social isolation, falls, depression, and mortality. Compared to their non-DSL peers, older adults with DSL experience various challenges in accessing healthcare, which were exacerbated during the COVID-19 pandemic. This study aimed to explore the continuum of geriatric care for older adults with DSL by integrating their perspectives, those of caregivers who accompany them on healthcare visits, and their healthcare providers in Canada during the pandemic. Method We conducted a qualitative study with 32 older Canadians with DSL and their caregivers, and an online survey with 228 healthcare providers across the country. Qualitative interviews were audio-recorded using Zoom and transcribed verbatim, while the survey data were collected using Lime Survey. Thematic analysis was used to analyse qualitative data, whereas descriptive statistics were used for quantitative survey data. Results The findings highlighted the gaps in the continuum of care for this population. The reported gaps were lack of training on DSL among healthcare providers, lack of time and comfort to go beyond one’s specialty, lack or limited support to overcome communication challenges while providing care to older adults with DSL, difficulty in using technologies for virtual/telehealth, presence of comorbidities such as cognitive impairment, and restrictions in caregiver accompaniment during the pandemic. Conclusion Our findings indicate that the continuum of care for this group is negatively affected due to the pandemic, in a disproportionate manner, and structural barriers are experienced by older adults with DSL and their caregivers for access to care. To ensure effective care, healthcare professionals need training on DSL-specific accessibility and communication. A collaborative, cross-disciplinary geriatric care approach with the active involvement of essential care partners is an utmost need.
Collapse
Affiliation(s)
- A Jaiswal
- Université de Montréal
- Institut Nazareth et Louis-Braille
| | | | | | | | | | | | | | | | | | | | - W Wittich
- Université de Montréal
- Institut Nazareth et Louis-Braille
- Centre de réadaptation Lethbridge-Layton-Mackay
| |
Collapse
|
19
|
Averill P, Vincent C, Reen G, Henderson C, Sevdalis N. Characterising the nature of the beast: Challenges associated with understanding patient safety within community-based mental health services. Eur Psychiatry 2022. [PMCID: PMC9567026 DOI: 10.1192/j.eurpsy.2022.1609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Introduction
Patient safety problems stemming from healthcare represent a significant cause of morbidity and mortality globally. The evidence base on safety in mental healthcare, particularly regarding community-based mental health services, has long fallen behind that of physical healthcare, with fewer research publications, developed primarily in isolation from the wider improvement science discipline. This disconnect both yields, and stems from, conceptual and practical challenges which must be surmounted in order to advance the science and improvement of safety in mental healthcare.
Objectives
The objectives of this research were to conduct a narrative review to provide an overview of conceptual issues in this area, their origins, and implications for patient safety science and clinical care. We also sought to identify approaches to overcoming these issues.
Methods
We examined theoretical and empirical evidence from the fields of patient safety, mental health, and improvement science to address this knowledge gap.
Results
We identified challenges with defining safety in the context of community mental healthcare, ascertaining what constitutes a ‘preventable’ safety problem requiring intervention, and in finding relevant research evidence. The research indicated that risk management has taken precedence over proactive safety promotion in mental healthcare. This positions service users as the origin of safety risks, with iatrogenic harm and latent system hazards associated with mental healthcare widely overlooked.
Conclusions
We propose a broader conceptualisation of safety to advance the field and outline potential next steps for the integration and uptake of different sources of ‘safety intelligence’ within community mental health services.
Disclosure
NS is the director of London Safety and Training Solutions Ltd, which offers training in patient safety, implementation solutions and human factors to healthcare organisations and the pharmaceutical industry. The other authors have no competing interests.
Collapse
|
20
|
Averill P, Vincent C, Reen G, Sevdalis N, Henderson C. Patient safety in community-based mental healthcare: A systematic scoping review. Eur Psychiatry 2022. [PMCID: PMC9566753 DOI: 10.1192/j.eurpsy.2022.1615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Introduction There is limited existing research about patient safety issues in mental healthcare. A lack of evidence is particularly pronounced in relation to safety in community-based mental health services, where the majority of care is provided. To date, reviews of mental health patient safety literature have focused primarily on inpatient care settings. Objectives This systematic scoping review will aim to identify and synthesise literature about the types of patient safety problems in adult community-based mental health settings, the causes of these problems, and evaluated safety interventions in this care context. Methods A systematic search was conducted on 19th June 2020 and refreshed on 23rd October 2021, across five databases: Medline, Embase, PsycINFO, Health Management Information Consortium, and Cumulative Index to Nursing and Allied Health Literature. The search strategy focused on three key elements: ‘mental health’, ‘patient safety’ and ‘community-based mental health services’. Retrieved articles were screened at title, abstract and subject heading level, followed by full-text screen of longlisted articles. Results In this presentation, the findings of this systematic scoping review will be described, based on synthesised literature about safety incidents, broader care delivery problems, their causes, and evaluated patient safety interventions to address these issues. Conclusions This study will offer learning opportunities about the safety problems, contributory factors, and safety interventions in adult community-based mental health services, as described in the evidence base. Review findings will also help to ascertain gaps in existing research, which should be addressed in future studies. Disclosure
NS is the director of London Safety and Training Solutions Ltd, which offers training in patient safety, implementation solutions and human factors to healthcare organisations and the pharmaceutical industry. The other authors have no competing interests.
Collapse
|
21
|
Demazière G, Vincent C, Plancke L, Paradis P. La qualité du codage de la tentative de suicide en psychiatrie de liaison. Rev Epidemiol Sante Publique 2022. [DOI: 10.1016/j.respe.2022.01.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
22
|
Joly CA, Reynard P, Mezzi K, Bakhos D, Bergeron F, Bonnard D, Borel S, Bouccara D, Coez A, Dejean F, Del Rio M, Leclercq F, Henrion P, Marx M, Mom T, Mosnier I, Potier M, Renard C, Roy T, Sterkers-Artières F, Venail F, Verheyden P, Veuillet E, Vincent C, Thai-Van H. Guidelines of the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL) and the French Society of Audiology (SFA) for Speech-in-Noise Testing in Adults. Eur Ann Otorhinolaryngol Head Neck Dis 2022; 139:21-27. [PMID: 34140263 DOI: 10.1016/j.anorl.2021.05.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
OBJECTIVES This document presents the fundamentals of speech audiometry in noise, general requirements for implementation and criteria for choice among the tests available in French according to the health-professional's needs. MATERIAL AND METHODS The recommendations are based on a systematic analysis of the literature carried out by a multidisciplinary group of doctors, audiologists and audioprosthetists from all over France. They are graded A, B, C or expert opinion according to decreasing level of scientific evidence. RESULTS Eight tests of speech audiometry in noise can be used in France. CONCLUSION To be complete, evaluation of hearing status requires testing understanding of speech in noise. The examination must begin with a minimum of two measurements familiarizing the subject with the test procedure. For initial diagnosis, adaptive procedures establishing the 50% speech reception threshold (SRT50) in noise are to be preferred in order to obtain a rapid and standardized measurement of perception of speech in noise. When the aim is to measure real-life speech comprehension, tests based on sentences, cocktail-party noise and free-field stimulation are to be preferred. Prosthetic gain is evaluated exclusively in free field. This is the only way to evaluate the contribution of binaurality and to measure perception in noise in an environment as close as possible to real life. In order to avoid acoustic interference in free field, at least five loudspeakers should be used, in particular for evaluating the effectiveness of directional microphones, CROS devices enabling sounds picked up in the damaged ear to be rerouted to the functional ear, or bimodal fitting (i.e., when hearing is enabled by two modalities: for example, hearing aid for one ear, cochlear implant for the other).
Collapse
Affiliation(s)
- C-A Joly
- Institut de l'Audition - Institut Pasteur, Inserm (French National Institute of Health and Medical Research), 75012 Paris, France; Department of Audiology and Otoneurological Evaluation, Edouard-Herriot Hospital, HCL (Hospices Civils de Lyon), 69003 Lyon, France
| | - P Reynard
- Institut de l'Audition - Institut Pasteur, Inserm (French National Institute of Health and Medical Research), 75012 Paris, France; Department of Audiology and Otoneurological Evaluation, Edouard-Herriot Hospital, HCL (Hospices Civils de Lyon), 69003 Lyon, France; Claude-Bernard University Lyon 1, 69100 Villeurbanne, France
| | - K Mezzi
- Department of Audiology and Otoneurological Evaluation, Edouard-Herriot Hospital, HCL (Hospices Civils de Lyon), 69003 Lyon, France
| | - D Bakhos
- Department of ENT and Head & Neck Surgery, University Hospital of Tours, 37000 Tours, France; iBrain, Inserm U1253, University of Tours, 37000 Tours, France
| | - F Bergeron
- Université Laval, Center for Interdisciplinary Research in Rehabilitation and Social Integration, G1V 0A6 Québec City, QC, Canada
| | - D Bonnard
- Institut de l'Audition - Institut Pasteur, Inserm (French National Institute of Health and Medical Research), 75012 Paris, France; Department of ENT, University Hospital of Bordeaux, 33000 Bordeaux, France
| | - S Borel
- Functional unit for auditory implants and audiovestibular testing, Department of Otorhinolaryngology, Ile de France reference centre for cochlear and brainstem implants in adults, Pitié-Salpêtrière Hospital Group, Sorbonne University, AP-HP, 75013 Paris, France
| | - D Bouccara
- Department of ENT and Head & Neck Oncology, Georges-Pompidou European Hospital, Paris Ouest University Hospitals, AP-HP, 75015 Paris, France
| | - A Coez
- Institut de l'Audition - Institut Pasteur, Inserm (French National Institute of Health and Medical Research), 75012 Paris, France; Laboratoire de correction auditive Eric Bizaguet, 750001 Paris, France
| | - F Dejean
- French Society of Audiology, 75116 Paris, France
| | - M Del Rio
- École d'Audioprothèse - Université de Bordeaux, 33000 Bordeaux, France; Caudéran Audition, 33200 Bordeaux, France
| | - F Leclercq
- Laboratoire d'Audiologie Renard, 59000 Lille, France; Department of Otology and Otoneurology, Salengro Hospital, University of Lille, 59000 Lille, France
| | - P Henrion
- French Society of Audiology, 75116 Paris, France
| | - M Marx
- Department of Otology, Otoneurology, and Paediatric Otorhinolaryngology, Pierre-Paul-Riquet Hospital, Toulouse Purpan University Hospital, 31000 Toulouse, France; Brain and Cognition Laboratory, UMR 5549, Toulouse III University, 31000 Toulouse, France
| | - T Mom
- Department of Otorhinolaryngology and Head & Neck Surgery, Gabriel-Montpied University Hospital, 63000 Clermont-Ferrand, France; Inserm UMR 1107, Sensorineural Biophysics Laboratory, Clermont-Auvergne University, 63000 Clermont-Ferrand, France
| | - I Mosnier
- Functional unit for auditory implants and audiovestibular testing, Department of Otorhinolaryngology, Ile de France reference centre for cochlear and brainstem implants in adults, Pitié-Salpêtrière Hospital Group, Sorbonne University, AP-HP, 75013 Paris, France
| | - M Potier
- Laboratoire d'Audiologie Clinique, 11100 Narbonne, France
| | - C Renard
- Laboratoire d'Audiologie Renard, 59000 Lille, France; Department of Otology and Otoneurology, Salengro Hospital, University of Lille, 59000 Lille, France
| | - T Roy
- Laboratoires F. Le Her, 76000 Rouen, France; Department of ENT and Head & Neck Surgery, Charles Nicolle University Hospital, 76000 Rouen, France
| | - F Sterkers-Artières
- Department of Audiophonology, Hôpital Institut Saint Pierre, 34250 Palavas Les Flots, France
| | - F Venail
- Department of ENT & Maxillofacial Surgery, Gui-de-Chauliac University Hospital, 34000 Montpellier, France; Inserm U1051, Institute for Neurosciences of Montpellier, University of Montpellier, 34000 Montpellier, France
| | - P Verheyden
- Department of Audiology, Haute Ecole Léonard de Vinci, Institut libre Marie Haps, Bruxelles, Belgium
| | - E Veuillet
- Institut de l'Audition - Institut Pasteur, Inserm (French National Institute of Health and Medical Research), 75012 Paris, France; Department of Audiology and Otoneurological Evaluation, Edouard-Herriot Hospital, HCL (Hospices Civils de Lyon), 69003 Lyon, France; Claude-Bernard University Lyon 1, 69100 Villeurbanne, France
| | - C Vincent
- Department of Otology and Otoneurology, Salengro Hospital, University of Lille, 59000 Lille, France
| | - H Thai-Van
- Institut de l'Audition - Institut Pasteur, Inserm (French National Institute of Health and Medical Research), 75012 Paris, France; Department of Audiology and Otoneurological Evaluation, Edouard-Herriot Hospital, HCL (Hospices Civils de Lyon), 69003 Lyon, France; Claude-Bernard University Lyon 1, 69100 Villeurbanne, France; French Society of Audiology, 75116 Paris, France.
| |
Collapse
|
23
|
McCarthy W, Golfinopoulos T, Woller KB, Vincent C, Kuang A, Labombard B. First application of a digital mirror Langmuir probe for real-time plasma diagnosis. Rev Sci Instrum 2021; 92:103502. [PMID: 34717421 DOI: 10.1063/5.0057318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/19/2021] [Accepted: 09/15/2021] [Indexed: 06/13/2023]
Abstract
For the first time, a digital Mirror Langmuir Probe (MLP) has successfully sampled plasma temperature, ion saturation current, and floating potential together on a single probe tip in real time in a radio-frequency driven helicon linear plasma device. This is accomplished by feedback control of the bias sweep to ensure a good fit to I-V characteristics with a high frequency, high power digital amplifier, and field-programmable gate array controller. Measurements taken by the MLP were validated by a low speed I-V characteristic manually collected during static plasma conditions. Plasma fluctuations, induced by varying the axial magnetic field (f̃ = 10 Hz), were also successfully monitored with the MLP. Further refinement of the digital MLP pushes it toward a turn-key system that minimizes the time to deployment and lessens the learning curve, positioning the digital MLP as a capable diagnostic for the study of low radio-frequency plasma physics. These demonstrations bolster confidence in fielding such digital MLP diagnostics in magnetic confinement experiments with high spatial and adequate temporal resolution, such as edge plasma, scrape-off layer, and divertor probes.
Collapse
Affiliation(s)
- W McCarthy
- Massachusetts Institute of Technology, Plasma Science and Fusion Center, 77 Massachusetts Ave., Cambridge, Massachusetts 02139, USA
| | - T Golfinopoulos
- Massachusetts Institute of Technology, Plasma Science and Fusion Center, 77 Massachusetts Ave., Cambridge, Massachusetts 02139, USA
| | - K B Woller
- Massachusetts Institute of Technology, Plasma Science and Fusion Center, 77 Massachusetts Ave., Cambridge, Massachusetts 02139, USA
| | - C Vincent
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon OX14 3DB, United Kingdom
| | - A Kuang
- Massachusetts Institute of Technology, Plasma Science and Fusion Center, 77 Massachusetts Ave., Cambridge, Massachusetts 02139, USA
| | - B Labombard
- Massachusetts Institute of Technology, Plasma Science and Fusion Center, 77 Massachusetts Ave., Cambridge, Massachusetts 02139, USA
| |
Collapse
|
24
|
Vincent C, Bodnaruc A, Prud'homme D, Giroux I. Gathering the Evidence on Diet and Depression: Results on Foods and Food Groups from an Umbrella Review. J Acad Nutr Diet 2021. [DOI: 10.1016/j.jand.2021.08.085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
25
|
Qnouch A, Solarczyk V, Verin J, Tourrel G, Stahl P, Danede F, Willart JF, Lemesre PE, Vincent C, Siepmann J, Siepmann F. Dexamethasone-loaded cochlear implants: How to provide a desired "burst release". Int J Pharm X 2021; 3:100088. [PMID: 34553137 PMCID: PMC8441626 DOI: 10.1016/j.ijpx.2021.100088] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/23/2021] [Revised: 06/03/2021] [Accepted: 06/06/2021] [Indexed: 12/20/2022]
Abstract
Cochlear implants containing iridium platinum electrodes are used to transmit electrical signals into the inner ear of patients suffering from severe or profound deafness without valuable benefit from conventional hearing aids. However, their placement is invasive and can cause trauma as well as local inflammation, harming remaining hair cells or other inner ear cells. As foreign bodies, the implants also induce fibrosis, resulting in a less efficient conduction of the electrical signals and, thus, potentially decreased system performance. To overcome these obstacles, dexamethasone has recently been embedded in this type of implants: into the silicone matrices separating the metal electrodes (to avoid short circuits). It has been shown that the resulting drug release can be controlled over several years. Importantly, the dexamethasone does not only act against the immediate consequences of trauma, inflammation and fibrosis, it can also be expected to be beneficial for remaining hair cells in the long term. However, the reported amounts of drug released at “early” time points (during the first days/weeks) are relatively low and the in vivo efficacy in animal models was reported to be non-optimal. The aim of this study was to increase the initial “burst release” from the implants, adding a freely water-soluble salt of a phosphate ester of dexamethasone. The idea was to facilitate water penetration into the highly hydrophobic system and, thus, to promote drug dissolution and diffusion. This approach was efficient: Adding up to 10% dexamethasone sodium phosphate to the silicone matrices substantially increased the resulting drug release rate at early time points. This can be expected to improve drug action and implant functionality. But at elevated dexamethasone sodium phosphate loadings device swelling became important. Since the cochlea is a tiny and sensitive organ, a potential increase in implant dimensions over time must be limited. Hence, a balance has to be found between drug release and implant swelling.
Collapse
Affiliation(s)
- A Qnouch
- Univ. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France
| | - V Solarczyk
- Univ. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France
| | - J Verin
- Univ. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France
| | - G Tourrel
- Oticon Medical, R&D, 06224 Vallauris, France
| | - P Stahl
- Oticon Medical, R&D, 06224 Vallauris, France
| | - F Danede
- Univ. Lille, UMR CNRS 8207, UMET, F-59655 Villeneuve d'Ascq, France
| | - J F Willart
- Univ. Lille, UMR CNRS 8207, UMET, F-59655 Villeneuve d'Ascq, France
| | - P E Lemesre
- Univ. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France
| | - C Vincent
- Univ. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France
| | - J Siepmann
- Univ. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France
| | - F Siepmann
- Univ. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France
| |
Collapse
|
26
|
Toulemonde P, Risoud M, Lemesre PE, Beck C, Wattelet J, Tardivel M, Siepmann J, Vincent C. Evaluation of the Efficacy of Dexamethasone-Eluting Electrode Array on the Post-Implant Cochlear Fibrotic Reaction by Three-Dimensional Immunofluorescence Analysis in Mongolian Gerbil Cochlea. J Clin Med 2021; 10:jcm10153315. [PMID: 34362099 PMCID: PMC8347204 DOI: 10.3390/jcm10153315] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2021] [Revised: 07/22/2021] [Accepted: 07/26/2021] [Indexed: 11/16/2022] Open
Abstract
Cochlear implant is the method of choice for the rehabilitation of severe to profound sensorineural hearing loss. The study of the tissue response to cochlear implantation and the prevention of post-cochlear-implant damages are areas of interest in hearing protection research. The objective was to assess the efficacy of dexamethasone-eluting electrode array on endo canal fibrosis formation by three-dimensional immunofluorescence analysis in implanted Mongolian gerbil cochlea. Two trials were conducted after surgery using Mongolian gerbil implanted with dexamethasone-eluting or non-eluting intracochlear electrode arrays. The animals were then euthanised 10 weeks after implantation. The cochleae were prepared (electrode array in place) according to a 29-day protocol with immunofluorescent labelling and tissue clearing. The acquisition was carried out using light-sheet microscopy. Imaris software was then used for three-dimensional analysis of the cochleae and quantification of the fibrotic volume. The analysis of 12 cochleae showed a significantly different mean volume of fibrosis (2.16 × 108 μm3 ± 0.15 in the dexamethasone eluting group versus 3.17 × 108 μm3 ± 0.54 in the non-eluting group) (p = 0.004). The cochlear implant used as a corticosteroid delivery system appears to be an encouraging device for the protection of the inner ear against fibrosis induced by implantation. Three-dimensional analysis of the cochlea by light-sheet microscopy was suitable for studying post-implantation tissue damage.
Collapse
Affiliation(s)
- Philippine Toulemonde
- Department of Otology and Neurotology, CHU Lille, University of Lille 2 Henri Warembourg, F-59000 Lille, France; (M.R.); (P.E.L.); (C.B.); (J.W.); (J.S.); (C.V.)
- INSERM U1008—Controlled Drug Delivery Systems and Biomaterials, F-59000 Lille, France
- Correspondence: ; Tel.: +33-6851-91052
| | - Michaël Risoud
- Department of Otology and Neurotology, CHU Lille, University of Lille 2 Henri Warembourg, F-59000 Lille, France; (M.R.); (P.E.L.); (C.B.); (J.W.); (J.S.); (C.V.)
- INSERM U1008—Controlled Drug Delivery Systems and Biomaterials, F-59000 Lille, France
| | - Pierre Emmanuel Lemesre
- Department of Otology and Neurotology, CHU Lille, University of Lille 2 Henri Warembourg, F-59000 Lille, France; (M.R.); (P.E.L.); (C.B.); (J.W.); (J.S.); (C.V.)
- INSERM U1008—Controlled Drug Delivery Systems and Biomaterials, F-59000 Lille, France
| | - Cyril Beck
- Department of Otology and Neurotology, CHU Lille, University of Lille 2 Henri Warembourg, F-59000 Lille, France; (M.R.); (P.E.L.); (C.B.); (J.W.); (J.S.); (C.V.)
- INSERM U1008—Controlled Drug Delivery Systems and Biomaterials, F-59000 Lille, France
| | - Jean Wattelet
- Department of Otology and Neurotology, CHU Lille, University of Lille 2 Henri Warembourg, F-59000 Lille, France; (M.R.); (P.E.L.); (C.B.); (J.W.); (J.S.); (C.V.)
- INSERM U1008—Controlled Drug Delivery Systems and Biomaterials, F-59000 Lille, France
| | - Meryem Tardivel
- BioImaging Center Lille-Nord de France (BICeL), University of Lille 2 Henri Warembourg, F-59000 Lille, France;
| | - Juergen Siepmann
- Department of Otology and Neurotology, CHU Lille, University of Lille 2 Henri Warembourg, F-59000 Lille, France; (M.R.); (P.E.L.); (C.B.); (J.W.); (J.S.); (C.V.)
- INSERM U1008—Controlled Drug Delivery Systems and Biomaterials, F-59000 Lille, France
| | - Christophe Vincent
- Department of Otology and Neurotology, CHU Lille, University of Lille 2 Henri Warembourg, F-59000 Lille, France; (M.R.); (P.E.L.); (C.B.); (J.W.); (J.S.); (C.V.)
- INSERM U1008—Controlled Drug Delivery Systems and Biomaterials, F-59000 Lille, France
| |
Collapse
|
27
|
Buchman CA, Gifford RH, Haynes DS, Lenarz T, O'Donoghue G, Adunka O, Biever A, Briggs RJ, Carlson ML, Dai P, Driscoll CL, Francis HW, Gantz BJ, Gurgel RK, Hansen MR, Holcomb M, Karltorp E, Kirtane M, Larky J, Mylanus EAM, Roland JT, Saeed SR, Skarzynski H, Skarzynski PH, Syms M, Teagle H, Van de Heyning PH, Vincent C, Wu H, Yamasoba T, Zwolan T. Unilateral Cochlear Implants for Severe, Profound, or Moderate Sloping to Profound Bilateral Sensorineural Hearing Loss: A Systematic Review and Consensus Statements. JAMA Otolaryngol Head Neck Surg 2021; 146:942-953. [PMID: 32857157 DOI: 10.1001/jamaoto.2020.0998] [Citation(s) in RCA: 65] [Impact Index Per Article: 21.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Importance Cochlear implants are a treatment option for individuals with severe, profound, or moderate sloping to profound bilateral sensorineural hearing loss (SNHL) who receive little or no benefit from hearing aids; however, cochlear implantation in adults is still not routine. Objective To develop consensus statements regarding the use of unilateral cochlear implants in adults with severe, profound, or moderate sloping to profound bilateral SNHL. Design, Setting, and Participants This study was a modified Delphi consensus process that was informed by a systematic review of the literature and clinical expertise. Searches were conducted in the following databases: (1) MEDLINE In-Process & Other Non-Indexed Citations and Ovid MEDLINE, (2) Embase, and (3) the Cochrane Library. Consensus statements on cochlear implantation were developed using the evidence identified. This consensus process was relevant for the use of unilateral cochlear implantation in adults with severe, profound, or moderate sloping to profound bilateral SNHL. The literature searches were conducted on July 18, 2018, and the 3-step Delphi consensus method took place over the subsequent 9-month period up to March 30, 2019. Main Outcomes and Measures A Delphi consensus panel of 30 international specialists voted on consensus statements about cochlear implantation, informed by an SR of the literature and clinical expertise. This vote resulted in 20 evidence-based consensus statements that are in line with clinical experience. A modified 3-step Delphi consensus method was used to vote on and refine the consensus statements. This method consisted of 2 rounds of email questionnaires and a face-to-face meeting of panel members at the final round. All consensus statements were reviewed, discussed, and finalized at the face-to-face meeting. Results In total, 6492 articles were identified in the searches of the electronic databases. After removal of duplicate articles, 74 articles fulfilled all of the inclusion criteria and were used to create the 20 evidence-based consensus statements. These 20 consensus statements on the use of unilateral cochlear implantation in adults with SNHL were relevant to the following 7 key areas of interest: level of awareness of cochlear implantation (1 consensus statement); best practice clinical pathway from diagnosis to surgery (3 consensus statements); best practice guidelines for surgery (2 consensus statements); clinical effectiveness of cochlear implantation (4 consensus statements); factors associated with postimplantation outcomes (4 consensus statements); association between hearing loss and depression, cognition, and dementia (5 consensus statements); and cost implications of cochlear implantation (1 consensus statement). Conclusions and Relevance These consensus statements represent the first step toward the development of international guidelines on best practices for cochlear implantation in adults with SNHL. Further research to develop consensus statements for unilateral cochlear implantation in children, bilateral cochlear implantation, combined electric-acoustic stimulation, unilateral cochlear implantation for single-sided deafness, and asymmetrical hearing loss in children and adults may be beneficial for optimizing hearing and quality of life for these patients.
Collapse
Affiliation(s)
- Craig A Buchman
- Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine in St Louis, St Louis, Missouri
| | - René H Gifford
- Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, Nashville, Tennessee
| | - David S Haynes
- Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Thomas Lenarz
- Department of Otorhinolaryngology, Hannover Medical School, Hannover, Germany
| | - Gerard O'Donoghue
- Department of Otology and Neurotology, University of Nottingham, Nottingham, United Kingdom.,Nottingham Biomedical Research Center, Nottingham University Hospitals National Health Service (NHS) Trust, Nottingham, United Kingdom
| | - Oliver Adunka
- Ohio State University Wexner Medical Center, The Ohio State University, Columbus
| | | | - Robert J Briggs
- Department of Otolaryngology, The University of Melbourne, Melbourne, Victoria, Australia.,Otology and Cochlear Implant Clinic, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia.,Department of Surgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia
| | - Matthew L Carlson
- Department of Otorhinolaryngology, Mayo Clinic School of Medicine, Rochester, Minnesota
| | - Pu Dai
- Department of Otolaryngology, General Hospital of People's Liberation Army, Beijing, China
| | - Colin L Driscoll
- Department of Otorhinolaryngology, Mayo Clinic School of Medicine, Rochester, Minnesota
| | - Howard W Francis
- Division of Head and Neck Surgery and Communication Sciences, Duke Surgery, Duke University School of Medicine, Durham, North Carolina
| | - Bruce J Gantz
- Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City
| | - Richard K Gurgel
- Division of Otolaryngology-Head & Neck Surgery, School of Medicine, University of Utah Hospital, Salt Lake City
| | - Marlan R Hansen
- Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City
| | - Meredith Holcomb
- Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston.,now with Department of Otolaryngology, University of Miami, Miami, Florida
| | - Eva Karltorp
- Cochlear Implant Department, Karolinska University Hospital, Stockholm, Sweden
| | - Milind Kirtane
- Department of ENT and Head Neck Surgery, Seth Gordhandas Sunderdas Medical College, King Edward Memorial Hospital, Mumbai, India
| | - Jannine Larky
- Cochlear Implant Center, Stanford University School of Medicine, Stanford, California
| | - Emmanuel A M Mylanus
- Department of Ear Nose Throat, Radboud University Medical Centre, Nijmegen, the Netherlands
| | - J Thomas Roland
- NYU Langone Health, New York University School of Medicine, New York
| | - Shakeel R Saeed
- Royal National Throat, Nose and Ear Hospital and University College London Ear Institute, London, United Kingdom
| | - Henryk Skarzynski
- Institute of Physiology and Pathology of Hearing, World Hearing Center, Kajetany, Nadarzyn, Poland
| | - Piotr H Skarzynski
- Institute of Physiology and Pathology of Hearing, World Hearing Center, Kajetany, Nadarzyn, Poland.,Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland.,Institute of Sensory Organs, Kajetany, Nadarzyn, Poland
| | | | - Holly Teagle
- School of Population Health-Audiology, The University of Auckland, Auckland, New Zealand
| | - Paul H Van de Heyning
- Department NKO & Head-Neck Surgery, Antwerp University Hospital, University of Antwerp, Edegem, Belgium
| | - Christophe Vincent
- Service d'Otologie et Oto-Neurologie, Centre Hospitalier Universitaire de Lille, Lille, France
| | - Hao Wu
- Department of Otolaryngology-Head and Neck Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Tatsuya Yamasoba
- Department of Otorhinolaryngology and Auditory and Voice Surgery, University of Tokyo Hospital, Tokyo, Japan
| | - Terry Zwolan
- Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor
| |
Collapse
|
28
|
Marx M, Mosnier I, Venail F, Mondain M, Uziel A, Bakhos D, Lescanne E, N'Guyen Y, Bernardeschi D, Sterkers O, Deguine O, Lepage B, Godey B, Schmerber S, Bonne NX, Vincent C, Fraysse B. Cochlear Implantation and Other Treatments in Single-Sided Deafness and Asymmetric Hearing Loss: Results of a National Multicenter Study Including a Randomized Controlled Trial. Audiol Neurootol 2021; 26:414-424. [PMID: 33789270 DOI: 10.1159/000514085] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2020] [Accepted: 12/28/2020] [Indexed: 11/19/2022] Open
Abstract
INTRODUCTION Cochlear implantation is a recent approach proposed to treat single-sided deafness (SSD) and asymmetric hearing loss (AHL). Several cohort studies showed its effectiveness on tinnitus and variable results on binaural hearing. The main objective of this study is to assess the outcomes of cochlear implantation and other treatment options in SSD/AHL on quality of life. METHODS This prospective multicenter study was conducted in 7 tertiary university hospitals and included an observational cohort study of SSD/AHL adult patients treated using contralateral routing of the signal (CROS) hearing aids or bone-anchored hearing systems (BAHSs) or who declined all treatments, and a randomized controlled trial in subjects treated by cochlear implantation, after failure of CROS and BAHS trials. In total, 155 subjects with SSD or AHL, with or without associated tinnitus, were enrolled. After 2 consecutive trials with CROS hearing aids and BAHSs on headband, all subjects chose any of the 4 treatment options (abstention, CROS, BAHS, or cochlear implant [CI]). The subjects who opted for a CI were randomized between 2 arms (CI vs. initial observation). Six months after the treatment choice, quality of life was assessed using both generic (EuroQoL-5D, EQ-5D) and auditory-specific quality-of-life indices (Nijmegen Cochlear implant Questionnaire [NCIQ] and Visual Analogue Scale [VAS] for tinnitus severity). Performances for speech-in-noise recognition and localization were measured as secondary outcomes. RESULTS CROS was chosen by 75 subjects, while 51 opted for cochlear implantation, 18 for BAHSs, and 11 for abstention. Six months after treatment, both EQ-5D VAS and auditory-specific quality-of-life indices were significantly better in the "CI" arm versus "observation" arm. The mean effect of the CI was particularly significant in subjects with associated severe tinnitus (mean improvement of 20.7 points ± 19.7 on EQ-5D VAS, 20.4 ± 12.4 on NCIQ, and 51.4 ± 35.4 on tinnitus). No significant effect of the CI was found on binaural hearing results. Before/after comparisons showed that the CROS and BAHS also improved significantly NCIQ scores (for CROS: +7.7, 95% confidence interval [95% CI] = [4.5; 10.8]; for the BAHS: +14.3, 95% CI = [7.9; 20.7]). CONCLUSION Cochlear implantation leads to significant improvements in quality of life in SSD and AHL patients, particularly in subjects with associated severe tinnitus, who are thereby the best candidates to an extension of CI indications.
Collapse
Affiliation(s)
- Mathieu Marx
- Service d'Otologie, Otoneurologie et ORL pédiatrique, Hôpital Pierre-Paul Riquet, CHU Purpan, Toulouse, France.,Brain & Cognition Research Centre, UMR 5549, Université Toulouse III, Toulouse, France
| | - Isabelle Mosnier
- AP-HP6, GHU Pitié-Salpêtrière, Service ORL, Unité Fonctionnelle Implants Auditifs et explorations fonctionnelles, Paris, France
| | - Frederic Venail
- Service d'ORL, Hôpital Gui de Chauliac, CHU, Montpellier, France
| | - Michel Mondain
- Service d'ORL, Hôpital Gui de Chauliac, CHU, Montpellier, France
| | - Alain Uziel
- Service d'ORL, Hôpital Gui de Chauliac, CHU, Montpellier, France
| | - David Bakhos
- Service d'ORL, Hôpital Bretonneau, CHU Tours, Tours, France
| | | | - Yann N'Guyen
- AP-HP6, GHU Pitié-Salpêtrière, Service ORL, Unité Fonctionnelle Implants Auditifs et explorations fonctionnelles, Paris, France
| | - Daniele Bernardeschi
- AP-HP6, GHU Pitié-Salpêtrière, Service ORL, Unité Fonctionnelle Implants Auditifs et explorations fonctionnelles, Paris, France
| | - Olivier Sterkers
- AP-HP6, GHU Pitié-Salpêtrière, Service ORL, Unité Fonctionnelle Implants Auditifs et explorations fonctionnelles, Paris, France
| | - Olivier Deguine
- Service d'Otologie, Otoneurologie et ORL pédiatrique, Hôpital Pierre-Paul Riquet, CHU Purpan, Toulouse, France.,Brain & Cognition Research Centre, UMR 5549, Université Toulouse III, Toulouse, France
| | - Benoît Lepage
- Unité de Soutien Méthodologique à la Recherche, Faculté de Médecine, Université de Toulouse, Toulouse, France
| | - Benoit Godey
- Service d'ORL, Hôpital Pontchaillou, CHU, Rennes, France
| | | | - Nicolas-Xavier Bonne
- Université Lille, Inserm, CHU Lille, Service d'ORL, U1192 - PRISM, Lille, France
| | | | - Bernard Fraysse
- Service d'Otologie, Otoneurologie et ORL pédiatrique, Hôpital Pierre-Paul Riquet, CHU Purpan, Toulouse, France
| |
Collapse
|
29
|
Thorley N, Chakravorty M, Schiff R, Oikonomou E, Symes R, Seymour E, Vincent C. 1 Quality of Care Transitions: Older Adults’ Experiences in An Integrated Care Trust. Age Ageing 2021. [DOI: 10.1093/ageing/afab028.01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
The transition of care from hospital to home is a high-risk time for older adults. The Partners at Care Transitions (PACT) programme aims to improve safety and quality of care transitions. We aimed to test the feasibility of using the Partners at Care Transitions Measure (PACT-M) to evaluate older adults’ experiences of the transition from hospital to home in an Inner London Integrated Care Trust and to identify factors impacting transition quality.
Methods
The PACT-M, a validated patient-reported questionnaire designed to evaluate care transitions, was administered to patients ≥65 years at 7, 30 and 90 days post-discharge. Likert scores were analysed quantitatively and manual thematic analysis performed on free-text comments.
Results
101 participants were recruited. Mean age 77.8 years. 84, 70 and 65 participants completed follow-up at 7, 30 and 90 days, respectively.
Factors impacting patients’ experience of transition quality are shown in Table 1.
Conclusions
Collapse
Affiliation(s)
- N Thorley
- Department of Ageing and Health, Guy’s and St Thomas’ NHS Foundation Trust
| | - M Chakravorty
- Department of Ageing and Health, Guy’s and St Thomas’ NHS Foundation Trust
| | - R Schiff
- Department of Ageing and Health, Guy’s and St Thomas’ NHS Foundation Trust
| | - E Oikonomou
- Department of Experimental Psychology, University of Oxford
| | - R Symes
- Department of Ageing and Health, Guy’s and St Thomas’ NHS Foundation Trust
| | - E Seymour
- Department of Ageing and Health, Guy’s and St Thomas’ NHS Foundation Trust
| | - C Vincent
- Department of Experimental Psychology, University of Oxford
| | | |
Collapse
|
30
|
Willems P, Hercun J, Vincent C, Alvarez F. A206 EVOLUTION OF PEDIATRIC AUTOIMMUNE CHOLANGITIS AND PRIMARY SCLEROSING CHOLANGITIS INTO ADULTHOOD. J Can Assoc Gastroenterol 2021. [DOI: 10.1093/jcag/gwab002.204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
The natural history of primary sclerosing cholangitis (PSC) in children seems to differ from PSC in adults. However, studies on this matter have been limited by short follow-up periods and inconsistent classification of patients with autoimmune cholangitis (AIC) (or overlap syndrome). Consequently, it remains unclear if long-term outcomes are affected by the clinical phenotype.
Aims
The aims of this is study are to describe the long-term evolution of PSC and AIC in a pediatric cohort with extension of follow-up into adulthood and to evaluate the influence of phenotype on clinical outcomes.
Methods
This is a retrospective study of patients with AIC or PSC followed at CHU-Sainte-Justine, a pediatric referral center in Montreal. All charts between January 1998 and December 2019 were reviewed. Patients were classified as either AIC (duct disease on cholangiography with histological features of autoimmune hepatitis) or PSC (large or small duct disease on cholangiography and/or histology). Extension of follow-up after the age of 18 was done for patients followed at the Centre hospitalier de l’Université de Montréal. Clinical features at diagnosis, response to treatment at one year and liver-related outcomes were compared.
Results
40 patients (27 PSC and 13 AIC) were followed for a median time of 71 months (range 2 to 347), with 52.5% followed into adulthood. 70% (28/40) had associated inflammatory bowel disease (IBD) (78% PSC vs 54% AIC; p=0.15). A similar proportion of patients had biopsy-proven significant fibrosis at diagnosis (45% PSC vs 67% AIC; p=0.23). Baseline liver tests were similar in both groups.
At diagnosis, all patients were treated with ursodeoxycholic acid. Significantly more patients with AIC (77% AIC vs 30 % PSC; p=0.005) were initially treated with immunosuppressive drugs, without a significant difference in the use of Anti-TNF agents (0% AIC vs 15% PSC; p= 0.12). At one year, 55% (15/27) of patients in the PSC group had normal liver tests versus only 15% (2/13) in the AIC group (p=0.02).
During follow-up, more liver-related events (cholangitis, liver transplant and cirrhosis) were reported in the AIC group (HR=3.7 (95% CI: 1.4–10), p=0.01). Abnormal liver tests at one year were a strong predictor of liver-related events during follow-up (HR=8.9(95% CI: 1.2–67.4), p=0.03), while having IBD was not (HR=0.48 (95% CI: 0.15–1.5), p=0.22). 5 patients required liver transplantation with no difference between both groups (8% CAI vs 15% CSP; p=0.53).
Conclusions
Pediatric patients with AIC and PSC show, at onset, similar stage of liver disease with comparable clinical and biochemical characteristics. However, patients with AIC receive more often immunosuppressive therapy and treatment response is less frequent. AIC is associated with more liver-related events and abnormal liver tests at one year are predictor of bad outcomes.
Funding Agencies
None
Collapse
Affiliation(s)
- P Willems
- 2. Centre Hospitalier de l’Universite de Montreal, Montreal, QC, Canada
| | - J Hercun
- 3. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
| | - C Vincent
- 2. Centre Hospitalier de l’Universite de Montreal, Montreal, QC, Canada
| | - F Alvarez
- 1. Centre Hospitalier Universitaire Sainte-Justine Departement de Pediatrie, Montreal, QC, Canada
| |
Collapse
|
31
|
Laccourreye O, Fakhry N, Franco-Vidal V, Jankowski R, Karkas A, Leboulanger N, Makeief M, Malard O, Michel J, Righini C, Rumeau C, Vincent C, Lisan Q. Statistics in scientific articles published in the European Annals of Otorhinolaryngology Head & Neck Diseases. Eur Ann Otorhinolaryngol Head Neck Dis 2021; 138:89-92. [DOI: 10.1016/j.anorl.2020.06.015] [Citation(s) in RCA: 32] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
32
|
Bolzer A, Hoen M, Montaut-Verient B, Hoffmann C, Ardoint M, Laplante-Lévesque A, Guevara N, Mom T, Karoui C, Vincent C, Parietti-Winkler C. The Development of the "Telislife" Questionnaire for the Evaluation of Telephone Use in Cochlear Implant Users. J Speech Lang Hear Res 2021; 64:186-195. [PMID: 33290146 DOI: 10.1044/2020_jslhr-20-00273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Purpose For cochlear implant users, the ability to use the telephone is often seen as an important landmark during rehabilitation and an indicator of cochlear implant benefit. The goal of this study was to develop a short questionnaire exploring the ability to use the telephone in cochlear implant users, named Telislife, and test it in a group of experienced users. Method This prospective multicenter study was based on the completion of self-administrated questionnaires. The Telislife includes 20 items using a 5-point Likert scale for answers. Speech recognition scores were obtained with monosyllabic word lists at 70 dB HL. Quality of life was evaluated with the Nijmegen Cochlear Implant Questionnaire. This study included 55 adult patients wearing a cochlear implant for over 1 year. Results The Telislife questionnaire showed excellent reliability (Cronbach's α = .91). A significant correlation was found between Telislife scores and Nijmegen Cochlear Implant Questionnaire scores (r = .69, p < .001) and speech recognition scores (r = .35, p = .007). Conclusion Given significant correlations between Telislife scores and both speech recognition and quality of life and given its short form, the Telislife questionnaire appears to be a reliable tool to evaluate cochlear implant outcomes in clinical practice. Supplemental Material https://doi.org/10.23641/asha.13322873.
Collapse
Affiliation(s)
| | - Michel Hoen
- Scientific and Clinical Research Group Cochlear Implants, Oticon Medical, Vallauris, France
| | | | - Charles Hoffmann
- Service d'ORL et CCF, CHU Nancy, France
- Laboratoire Développement, Adaptation et Handicap (DevAH-EA 3450), Faculty of Medicine and Faculty of Sciences and Sport, University of Lorraine, Vandœuvre-lès-Nancy, France
| | - Marine Ardoint
- Scientific and Clinical Research Group Cochlear Implants, Oticon Medical, Vallauris, France
| | | | | | - Thierry Mom
- Service ORL et CCF, CHU Gabriel Montpied, Clermont-Ferrand, France
| | - Chadlia Karoui
- Scientific and Clinical Research Group Cochlear Implants, Oticon Medical, Vallauris, France
| | | | - Cécile Parietti-Winkler
- Service d'ORL et CCF, CHU Nancy, France
- Laboratoire Développement, Adaptation et Handicap (DevAH-EA 3450), Faculty of Medicine and Faculty of Sciences and Sport, University of Lorraine, Vandœuvre-lès-Nancy, France
| |
Collapse
|
33
|
Marx M, Mosnier I, Vincent C, Bonne NX, Bakhos D, Lescanne E, Flament J, Bernardeschi D, Sterkers O, Fraysse B, Lepage B, Godey B, Schmerber S, Uziel A, Mondain M, Venail F, Deguine O. Treatment choice in single-sided deafness and asymmetric hearing loss. A prospective, multicentre cohort study on 155 patients. Clin Otolaryngol 2020; 46:736-743. [PMID: 33236413 DOI: 10.1111/coa.13672] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2020] [Revised: 10/29/2020] [Accepted: 11/08/2020] [Indexed: 11/26/2022]
Abstract
OBJECTIVES To describe the treatment choice in a cohort of subjects with single-sided deafness (SSD) and asymmetric hearing loss (AHL). To assess the reliability of the treatment trials. DESIGN In this national, multicentre, prospective study, the choice of subjects was made after two consecutive trials of Contralateral Routing Of the Signal (CROS) hearing aids and a Bone Conduction Device (BCD) on a headband. Subjects could proceed with one of these two options, opt for cochlear implantation or decline all treatments. SETTING Seven tertiary university hospitals. PARTICIPANTS One hundred fifty-five subjects with SSD or AHL fulfilling the candidacy criteria for cochlear implantation, with or without associated tinnitus. MAIN OUTCOME MEASURES After the two trials, the number of subjects choosing each option was described. Repeated assessments of both generic and auditory-specific quality of life were conducted, as well as hearing assessments (speech recognition in noise and horizontal localization). RESULTS CROS was chosen by 75 subjects, followed by cochlear implantation (n = 51), BCD (n = 18) and abstention (n = 11). Patients who opted for cochlear implantation had a poorer quality of life (P = .03). The improvement of quality of life indices after each trial was significantly associated with the final treatment choice (P = .008 for generic indices, P = .002 for auditory-specific indices). The follow-up showed that this improvement had been overestimated in the CROS group, with a long-term retention rate of 52.5%. CONCLUSIONS More than one third of SSD/AHL subjects are unsatisfied after CROS and BCD trials. Repeated quality of life assessments help counselling the patient for his/her treatment choice.
Collapse
Affiliation(s)
- Mathieu Marx
- Service d'Otologie, Otoneurologie et ORL Pédiatrique, Hôpital Pierre-Paul Riquet, CHU Toulouse Purpan, France.,Brain & Cognition Research Centre, UMR 5549, Université Toulouse III, France
| | - Isabelle Mosnier
- AP-HP, GHU Pitié-Salpêtrière, Service ORL, Otologie, Implants Auditifs et Chirurgie de la Base du Crâne, Paris, France
| | | | | | - David Bakhos
- Service d'ORL, Hôpital Bretonneau, CHU Tours, Tours, France
| | | | - Jonathan Flament
- AP-HP, GHU Pitié-Salpêtrière, Service ORL, Otologie, Implants Auditifs et Chirurgie de la Base du Crâne, Paris, France.,Laboratoire Audika, Paris, France
| | - Daniele Bernardeschi
- AP-HP, GHU Pitié-Salpêtrière, Service ORL, Otologie, Implants Auditifs et Chirurgie de la Base du Crâne, Paris, France
| | - Olivier Sterkers
- AP-HP, GHU Pitié-Salpêtrière, Service ORL, Otologie, Implants Auditifs et Chirurgie de la Base du Crâne, Paris, France
| | - Bernard Fraysse
- Service d'Otologie, Otoneurologie et ORL Pédiatrique, Hôpital Pierre-Paul Riquet, CHU Toulouse Purpan, France
| | - Benoit Lepage
- Unité de Soutien Méthodologique à la Recherche, Faculté de Médecine, Université de Toulouse, Toulouse, France
| | - Benoit Godey
- Service d'ORL, Hôpital Pontchaillou, CHU Rennes, Rennes, France
| | | | - Alain Uziel
- Service d'ORL, Hôpital Gui de Chauliac, CHU Montpellier, Montpellier, France
| | - Michel Mondain
- Service d'ORL, Hôpital Gui de Chauliac, CHU Montpellier, Montpellier, France
| | - Frédéric Venail
- Service d'ORL, Hôpital Gui de Chauliac, CHU Montpellier, Montpellier, France
| | - Olivier Deguine
- Service d'Otologie, Otoneurologie et ORL Pédiatrique, Hôpital Pierre-Paul Riquet, CHU Toulouse Purpan, France.,Brain & Cognition Research Centre, UMR 5549, Université Toulouse III, France
| |
Collapse
|
34
|
Vincent C, Couloigner V, Lescanne E, Thai-Van H. Don't turn a blind eye to the Decree of November 14, 2018 in the French Journal Officiel. Eur Ann Otorhinolaryngol Head Neck Dis 2020; 138:3-4. [PMID: 33250365 DOI: 10.1016/j.anorl.2020.11.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- C Vincent
- Secrétaire général de l'Association Française d'Otologie et d'Otoneurologie, France.
| | - V Couloigner
- Secrétaire général de la Société Française d'ORL, France
| | - E Lescanne
- Président du Collège ORL, collège Français d'ORL, France
| | - H Thai-Van
- Président de la Société Française d'Audiologie, France
| |
Collapse
|
35
|
Thai-Van H, Bakhos D, Bouccara D, Loundon N, Marx M, Mom T, Mosnier I, Roman S, Villerabel C, Vincent C, Venail F. Telemedicine in Audiology. Best practice recommendations from the French Society of Audiology (SFA) and the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL). Eur Ann Otorhinolaryngol Head Neck Dis 2020; 138:363-375. [PMID: 33097467 PMCID: PMC7575454 DOI: 10.1016/j.anorl.2020.10.007] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
Objectives Access to diagnosis and treatments for auditory disorders and related pathologies has regressed in France during the COVID-19 pandemic, posing a risk to the patient's chance of recovery. This best practice recommendations guide aims to list the existing technological solutions for the remote examination of a patient with hearing complaint, and to outline their benefits and, where applicable, their limitations. Methods The recommendations were developed both from the clinical experience of the medical experts who drafted the guide, and from an extensive review of the literature dealing with clinical practice recommendations for tele-audiology. Tele-audiometry solutions were identified on the basis of a search engine query carried out in April 2020, prior to verification of their availability on the European market. Results Video otoscopy solutions allow for the teletransmission of images compatible with a high-quality diagnosis, either by connecting via internet to a tele-health platform or using a smartphone or a tablet with an iOS or Android operating system. Using the same telecommunication methods, it is possible to remotely conduct a pure-tone audiometry test in accordance with standard practice, a speech-in-quiet or a speech-in-noise audiometry test, as well as objective measures of hearing. Clinical and paraclinical examinations can be accessed by the physician to be interpreted on a deferred basis (asynchronous tele-audiology). Examinations can also be conducted in real time in a patient, at any age of life, as long as a caregiver can be present during the installation of the transducers or the acoumetry. Tele-audiology solutions also find application in the remote training of future healthcare professionals involved in the management of deafness and hearing impairment. Conclusion Under French law, tele-otoscopy is a medical procedure that is either a tele-expertise (asynchronous adive) or a teleconsultation act (synchronous advice). Subjective and objective evaluation of the patient's hearing functions can be done remotely provided that the listed precautions are respected.
Collapse
Affiliation(s)
- H Thai-Van
- Department of Audiology and Otoneurological Evaluation, Edouard-Herriot Hospital, HCL (hospices civils de Lyon), 69003 Lyon, France; Claude-Bernard University Lyon 1, 69100 Villeurbanne, France; Inserm (French National Institute of Health and Medical Research) U1120, Hearing Institute-Paris, Research Centre of Institut Pasteur, 75012 Paris, France.
| | - D Bakhos
- Faculty of Medicine, University of Tours, 10, boulevard Tonnellé, 37000 Tours, France; Inserm U1253, ibrain, 37044 Tours, France
| | - D Bouccara
- Department of ENT and Head & Neck Oncology, Georges-Pompidou European Hospital, Paris Ouest University Hospitals, AP-HP, 75015 Paris, France; SOFRESC (French Society of Sensory and Cognitive Research), 92130 Issy-les-Moulineaux, France
| | - N Loundon
- Department of ENT & Maxillofacial Surgery, Necker Children's University Hospital, 75015 Paris, France; Inserm U587, Genetics of Deafness Unit, IMAGINE, 75015 Paris, France
| | - M Marx
- Department of Otology, Otoneurology, and Paediatric Otorhinolaryngology, Pierre-Paul-Riquet Hospital, Toulouse Purpan University Hospital, 31000 Toulouse, France; Brain and Cognition Laboratory, UMR 5549, Toulouse III University, 31000 Toulouse, France
| | - T Mom
- Department of Otorhinolaryngology and Head & Neck Surgery, Gabriel-Montpied University Hospital, 63000 Clermont-Ferrand, France; Inserm UMR 1107, Sensorineural Biophysics Laboratory, Clermont-Auvergne University, 63000 Clermont-Ferrand, France
| | - I Mosnier
- Functional unit for auditory implants and audiovestibular testing, Department of Otorhinolaryngology, île de France reference centre for cochlear and brainstem implants in adults, Pitié-Salpêtrière Hospital Group, Sorbonne University, AP-HP, 75013 Paris, France
| | - S Roman
- Department of ENT, Timone Children's Hospital, AP-HM (Assistance publique-Hôpitaux de Marseille), 13385 Marseille cedex 5, France; La Timone Faculty of Medicine, UMR 1106, The institut de neurosciences des systèmes, 13005 Marseille, France
| | - C Villerabel
- Department of ENT & Maxillofacial Surgery, Gui-de-Chauliac University Hospital, 34000 Montpellier, France; Inserm U1051, Institute for Neurosciences of Montpellier, University of Montpellier, 34000 Montpellier, France
| | - C Vincent
- Department of Otology and Otoneurology, Salengro Hospital, University of Lille, 59000 Lille, France
| | - F Venail
- Department of ENT & Maxillofacial Surgery, Gui-de-Chauliac University Hospital, 34000 Montpellier, France; Inserm U1051, Institute for Neurosciences of Montpellier, University of Montpellier, 34000 Montpellier, France
| |
Collapse
|
36
|
Gauvrit F, Risoud M, Aubry K, Bordure P, Bozorg-Grayeli A, Deguine O, Eyermann C, Franco-Vidal V, Godey B, Guevara N, Karkas A, Klopp N, Labrousse M, Lebreton JP, Lerosey Y, Lescanne E, Loundon N, Marianowski R, Merklen F, Mezouaghi K, Mom T, Moreau S, Mosnier I, Noël-Petroff N, Parietti C, Piller P, Poncet C, Radafy E, Roman S, Roux-Vaillard S, Schmerber S, Tavernier L, Truy E, Vincent C. The French Cochlear Implant Registry (EPIIC): General indicators. Eur Ann Otorhinolaryngol Head Neck Dis 2020; 137 Suppl 1:S5-S9. [PMID: 32891589 DOI: 10.1016/j.anorl.2020.07.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Cochlear and brainstem implants have been included on the list of reimbursable products (LPPR) in France since March of 2009. The implants were initially inscribed for 5 years, after which an application for renewal with the French National Commission for the Evaluation of Medical Devices and Health Technologies (Commission Nationale d'évaluation des dispositifs médicaux et des technologies de santé - CNEDiMTS) was required [Haute Autorité de santé, 2009]. Upon registration to the list of reimbursable products, the companies and the reference centers for cochlear and brainstem implants were asked to set up a post-registration registry called EPIIC. This article reports the evolution in the EPIIC registry of the general indicators for 5051 patients over the five years from 2012-2016.
Collapse
Affiliation(s)
- F Gauvrit
- Service d'Otologie et d'Otoneurologie, CHU de Lille, rue Emile-Laine, 59037 Lille, France
| | - M Risoud
- Service d'Otologie et d'Otoneurologie, CHU de Lille, rue Emile-Laine, 59037 Lille, France
| | - K Aubry
- CHU de Limoges, Limoges, France
| | | | | | | | | | | | - B Godey
- CHU de Rennes, Rennes, France
| | | | - A Karkas
- CHU de St Etienne, Saint-Etienne, France
| | - N Klopp
- CHU d'Amiens, Amiens, France
| | | | | | | | | | | | | | - F Merklen
- CHU de Montpellier, Montpellier, France
| | | | - T Mom
- CHU de Clermont-Ferrand, Clermont-Ferrand, France
| | | | - I Mosnier
- Hôpital Pitié-Salpétrière, Paris, France
| | | | | | - P Piller
- CHT de Nouméa - Nouvelle-Calédonie, France
| | - C Poncet
- Hôpital Rothschild, Paris, France
| | - E Radafy
- CH du Lamentin, Martinique, France
| | - S Roman
- CHU de Marseille, Marseille, France
| | | | | | | | - E Truy
- CHU de Lyon, Lyon, France
| | - C Vincent
- Service d'Otologie et d'Otoneurologie, CHU de Lille, rue Emile-Laine, 59037 Lille, France.
| |
Collapse
|
37
|
Puechmaille M, Lambert C, Aubry K, Bordure P, Bozorg-Grayeli A, Deguine O, Eyermann C, Franco-Vidal V, Godey B, Guevara N, Karkas A, Klopp N, Labrousse M, Lebreton JP, Lerosey Y, Lescanne E, Loundon N, Marianowski R, Merklen F, Mezouaghi K, Moreau S, Mosnier I, Noël-Petroff N, Parietti-Winkler C, Piller P, Poncet C, Radafy E, Roman S, Roux-Vaillard S, Schmerber S, Tavernier L, Truy E, Vincent C, Mom T. The French National Cochlear Implant Registry (EPIIC): Bilateral cochlear implantation. Eur Ann Otorhinolaryngol Head Neck Dis 2020; 137 Suppl 1:S51-S56. [DOI: 10.1016/j.anorl.2020.07.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
38
|
Herman P, Vincent C, Parietti Winkler C, Loundon N, Couloigner V, Tankere F, Tringali S, Gallet P, Papon JF, Montava M, Lavieille JP, Charpiot A, Schmerber S. Conseils de bonne pratique. Corticothérapie en ORL en contexte de pandémie COVID-19. Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale 2020. [PMCID: PMC7198192 DOI: 10.1016/j.aforl.2020.04.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
39
|
Parent V, Codet M, Aubry K, Bordure P, Bozorg-Grayeli A, Deguine O, Eyermann C, Franco-Vidal V, Guevara N, Karkas A, Klopp N, Labrousse M, Lebreton JP, Lerosey Y, Lescanne E, Loundon N, Marianowski R, Merklen F, Mezouaghi K, Mom T, Moreau S, Mosnier I, Noël-Petroff N, Parietti-Winkler C, Piller P, Poncet C, Radafy E, Roman S, Roux-Vaillard S, Schmerber S, Tavernier L, Truy E, Vincent C, Godey B. The French Cochlear Implant Registry (EPIIC): Cochlear implantation complications. Eur Ann Otorhinolaryngol Head Neck Dis 2020; 137 Suppl 1:S37-S43. [PMID: 32861600 DOI: 10.1016/j.anorl.2020.07.007] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
OBJECTIVES The aim of this study was to evaluate peri- and post-operative complications related to cochlear implantations. We searched for risk factors predicting these complications and analyzed the complications in the youngest and most elderly. STUDY DESIGN Retrospective analysis of cochlear implant patients. MATERIALS AND METHODS All patients who underwent cochlear implantation in France between January 2012 and December 2016 were anonymized and registered in the EPIIC database. This population included 3483 adults and 2245 children. Their demographic and surgical data and their incidence of peri- or post-operative complications, including their severity, whether major or minor, were all indicated. RESULTS The global complication rate was 6.84%. The risk of complication was higher in initial implantation versus reimplantation (P<0.0001). The risk was also higher for bilateral implantation versus unilateral (P<0.0001). Complications were more frequent for patients with cochlear malformation (P=0.002). There was no difference in complication rates across age groups; babies under 1 year old, and the elderly over 80 and even over 90, did not have more complications than the rest of the population. Patients treated in the daily care unit had no more complications than those who were hospitalized for one night or more (P=0.64). CONCLUSION Cochlear implantation is a safe technique with a low incidence of complications. The absence of increased risk in patients at the extremes of the age spectrum justifies offering this solution to all, without age limitation.
Collapse
Affiliation(s)
- V Parent
- Service ORL et chirurgie cervico-faciale, hôpital Pontchaillou, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 9, France
| | - M Codet
- Service ORL et chirurgie cervico-faciale, hôpital Pontchaillou, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 9, France
| | - K Aubry
- CHU de Limoges, Limoges, France
| | | | | | | | | | | | | | - A Karkas
- CHU de St Etienne, Saint-Etienne, France
| | - N Klopp
- CHU d'Amiens, Amiens, France
| | | | | | | | | | | | | | - F Merklen
- CHU de Montpellier, Montpellier, France
| | | | - T Mom
- CHU de Clermont-Ferrand, Clermont-Ferrand, France
| | | | - I Mosnier
- Hôpital Pitié-Salpétrière, Paris, France
| | | | | | - P Piller
- CH de Nouméa, Nouméa, Nouvelle-Calédonie
| | - C Poncet
- Hôpital Rothschild, Paris, France
| | - E Radafy
- CH du Lamentin, Martinique, France
| | - S Roman
- CHU de Marseille, Marseille, France
| | | | | | | | - E Truy
- CHU de Lyon, Lyon, France
| | | | - B Godey
- Service ORL et chirurgie cervico-faciale, hôpital Pontchaillou, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 9, France.
| |
Collapse
|
40
|
Vincent C, Pierre M, Stinziano J. Racing against stomatal attenuation: rapid CO 2 response curves more reliably estimate photosynthetic capacity than steady state curves in a low conductance species.. [PMID: 0 DOI: 10.1101/2020.08.28.270785] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
AbstractA/Ci curves are an important gas-exchange-based approach to understanding the regulation of photosynthesis, describing the response of net CO2 assimilation (A) to leaf internal concentration of CO2 (Ci). Low stomatal conductance species pose a challenge to the measurement of A/Ci curves by reducing the signal-to-noise ratio of gas exchange measures. Additionally, the stomatal attenuation effect of elevated ambient CO2 leads to further reduction of conductance and may lead to erroneous interpretation of high Ci responses of A. Rapid A/Ci response (RACiR) curves offer a potential practice to develop A/Ci curves faster than the stomatal closure response to elevated CO2. We used the moderately low conductance Citrus to compare traditional steady state (SS) A/Ci curves with RACiR curves. SS curves failed more often than RACiR curves. Overall parameter estimates were the same between SS and RACiR curves. When low stomatal conductance values were removed, triose-phosphate utilization (TPU) limitation estimates increased. Overall RACiR stomatal conductance values began and remained higher than SS values. Based on the comparable resulting parameter estimates, higher likelihood of success and reduced measurement time, we propose RACiR as a valuable tool to measure A/Ci responses in low conductance species.
Collapse
|
41
|
Loundon N, Simon F, Aubry K, Bordure P, Bozorg-Grayeli A, Deguine O, Eyermann C, Franco-Vidal V, Godey B, Guevara N, Karkas A, Klopp N, Labrousse M, Lebreton JP, Lerosey Y, Lescanne E, Marianowski R, Merklen F, Mezouaghi K, Mom T, Moreau S, Mosnier I, Noël-Petroff N, Parietti-Winkler C, Piller P, Poncet C, Radafy E, Roman S, Roux-Vaillard S, Schmerber S, Tavernier L, Truy E, Vincent C, De Lamaze A. The French Cochlear Implant Registry (EPIIC): Perception and language results in infants with cochlear implantation under the age of 24 months. Eur Ann Otorhinolaryngol Head Neck Dis 2020; 137 Suppl 1:S11-S18. [PMID: 32863156 DOI: 10.1016/j.anorl.2020.07.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE Multi-centre study of the National French Registry (EPIIC) of patients with cochlear implants, focusing on infants who were operated-on under the age of 24 months between 2012 and 2016. PATIENTS AND METHODS A total of 615 profoundly deaf infants, who received cochlear implants (CIs) before their second birthday, were included in the registry by different CI centers. Epidemiological, surgical, speech therapy and school, follow-up data were included in the registry, 12, 24, 36 and 48 months thereafter. The following parameters were studied: type of implantation (uni- or bilateral), complications, cause of deafness, category of auditory perception (CAP), Open-set word recognition score (OSW), speech intelligibility rating, lexical comprehension with EVIP (Peabody), communication mode and type of schooling. Bilateral simultaneous CI (BiCI) and unilateral CI (UniCI) groups were compared. RESULTS There were 744 implantations. The explantation-reimplantation rate, within the four-year follow-up, was just 3.6%. Mean implantation age was 16.0 months, and similar in the two groups (BiCI/UniCI). A total of 51% of children had their first implant between 12 and 18 months, and 15% before 12 months. Implantation was unilateral in 52% of cases. Fifty-six percent of the bilateral procedures were sequential, with a mean delay of 16.8 months for the second implantation. The cause of deafness was unknown in 52% of cases. Of the 48% (297/615) of attributed cases, 32% had clear genetic causes. The remaining deafness was due to cytomegalovirus (CMV, 8%), inner-ear malformation (5%) and meningitis (3%). The main complications were from infections (47%) and internal device failure (25%). Four years post-operation, 84% of the UniCI and 75% of BiCl groups had a CAP≥5, and 83% of UniCl and 100% BiCI had OSW≥80%. Furthermore 74% of UniCI and 77% of BiCI communicated orally and 85% of UniCI and 90% of BiCI integrated into mainstream schooling. CONCLUSION The French Registry of cochlear implants (EPIIC) is the only such national registry in the world. Our analysis illustrates the immediate benefits of, either single or double, cochlear implantation for language, perception skills and schooling.
Collapse
Affiliation(s)
- N Loundon
- Department of Pediatric Otolaryngology, Hôpital Necker-Enfants-Malades, 149, rue de Sèvres, 75015 Paris, France.
| | - F Simon
- Department of Pediatric Otolaryngology, Hôpital Necker-Enfants-Malades, 149, rue de Sèvres, 75015 Paris, France
| | - K Aubry
- CHU de Limoges, Limoges, France
| | | | | | | | | | | | - B Godey
- CHU de Rennes, Rennes, France
| | | | - A Karkas
- CHU de St Etienne, Saint-Etienne, France
| | - N Klopp
- CHU d'Amiens, Amiens, France
| | | | | | | | | | | | - F Merklen
- CHU de Montpellier, Montpellier, France
| | | | - T Mom
- CHU de Clermont-Ferrand, Clermont-Ferrand, France
| | | | - I Mosnier
- Hôpital Pitié-Salpétrière, Paris, France
| | | | | | - P Piller
- CH de Nouméa, Nouméa, Nouvelle-Calédonie
| | - C Poncet
- Hôpital Rothschild, Paris, France
| | - E Radafy
- CH du Lamentin, Martinique, France
| | - S Roman
- CHU de Marseille, Marseille, France
| | | | | | | | - E Truy
- CHU de Lyon, Lyon, France
| | | | - A De Lamaze
- Department of Pediatric Otolaryngology, Hôpital Necker-Enfants-Malades, 149, rue de Sèvres, 75015 Paris, France
| |
Collapse
|
42
|
Hermann R, Coudert A, Aubry K, Bordure P, Bozorg-Grayeli A, Deguine O, Eyermann C, Franco-Vidal V, Godey B, Guevara N, Karkas A, Klopp N, Labrousse M, Lebreton JP, Lerosey Y, Lescanne E, Loundon N, Marianowski R, Merklen F, Mezouaghi K, Mom T, Moreau S, Mosnier I, Noël-Petroff N, Parietti-Winkler C, Piller P, Poncet C, Radafy E, Roman S, Roux-Vaillard S, Schmerber S, Tavernier L, Vincent C, Truy E. The French National Cochlear Implant Registry (EPIIC): Cochlear explantation and reimplantation. Eur Ann Otorhinolaryngol Head Neck Dis 2020; 137 Suppl 1:S45-S49. [PMID: 32826202 DOI: 10.1016/j.anorl.2020.07.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
This study aims to determine the frequency and causes of cochlear explants with re-implantation (ERI) after 5 years' follow up of the patients included in the French national EPIIC (étude post-inscription des implants cochléaires) registry tracking patients with cochlear implantation. This multicenter, descriptive prospective study was conducted on 5051 patients enrolled in the EPIIC database between January 2012 and December 2016. Ninety-five patients (1.9%) received a primary implant and an ERI during the study. Of these, four benefitted from two ERIs. The number of ERIs was significantly higher in the pediatric population than among adults. The explantation and reimplantation were performed simultaneously in 86% of cases. The reasons for explantation were: in 46.4% of cases linked to a malfunction of the implant, and in 39.3% of cases for medical or surgical reasons. The number of electrodes inserted was significantly higher after the ERI than after the first implantation. There was just one post-ERI infection for these 95 explanted and re-implanted patients. As well as explantation with reimplantation rarely being necessary, it generally presents no major surgical difficulty and in most cases it allows a better integration than in the first implantation.
Collapse
Affiliation(s)
- R Hermann
- Otorhinolaryngology department and Head and Neck Surgery, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
| | - A Coudert
- Otorhinolaryngology department and Head and Neck Surgery, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
| | - K Aubry
- CHU de Limoges, Limoges, France
| | | | | | | | | | | | - B Godey
- CHU de Rennes, Rennes, France
| | | | - A Karkas
- CHU de St Etienne, Saint-Etienne, France
| | - N Klopp
- CHU d'Amiens, Amiens, France
| | | | | | | | | | | | | | - F Merklen
- CHU de Montpellier, Montpellier, France
| | | | - T Mom
- CHU de Clermont-Ferrand, Clermont-Ferrand, France
| | | | - I Mosnier
- Hôpital Pitié-Salpétrière, Paris, France
| | | | | | - P Piller
- CH de Nouméa, Nouméa, Nouvelle-Calédonie
| | - C Poncet
- Hôpital Rothschild, Paris, France
| | - E Radafy
- CH du Lamentin, Martinique, France
| | - S Roman
- CHU de Marseille, Marseille, France
| | | | | | | | | | - E Truy
- Otorhinolaryngology department and Head and Neck Surgery, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.
| |
Collapse
|
43
|
Artières-Sterkers F, Mondain M, Aubry K, Bordure P, Bozorg-Grayeli A, Deguine O, Eyermann C, Franco-Vidal V, Godey B, Guevara N, Karkas A, Klopp N, Labrousse M, Lebreton JP, Lerosey Y, Lescanne E, Loundon N, Marianowski R, Merklen F, Mezouaghi K, Mom T, Moreau S, Mosnier I, Noël-Petroff N, Parietti-Winkler C, Piller P, Poncet C, Radafy E, Roman S, Roux-Vaillard S, Schmerber S, Tavernier L, Truy E, Vincent C, Uziel A. The French National Cochlear Implant Registry (EPIIC): Results, quality of life, questionnaires, academic and professional life. Eur Ann Otorhinolaryngol Head Neck Dis 2020; 137 Suppl 1:S57-S63. [PMID: 32792302 DOI: 10.1016/j.anorl.2020.07.013] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
This study concerns the results of cochlear implantation in children and adults from French cochlear implantation centers, monitored at one, two and three years by the Cochlear Implant French Registry EPIIC. This multicenter study enrolled 2603 subjects (1667 adults and 936 children) implanted in one ear. The following parameters were studied: hearing overall performances, monosyllabic or dissyllabic word perception, speech intelligibility, self-assessment questionnaire of Cochlear Implant (CI) benefits (Abbreviated profile of Hearing aid Benefit); professional activity and schooling. This study confirms the ceiling effect in adults' performances after the 1st year and the progressive growth in children's performances. It also shows that the contralateral hearing aid enhances performances compared to the CI alone condition, in all follow-up sessions. The French register of CIs is the only worldwide register of systematic follow-up on a period of three years and more of all adults and children implanted in a country.
Collapse
Affiliation(s)
| | - M Mondain
- Service ORL, CHU de Montpellier, Montpellier, France
| | - K Aubry
- CHU de Limoges, Limoges, France
| | | | | | | | | | | | - B Godey
- CHU de Rennes, Rennes, France
| | | | - A Karkas
- CHU de St Etienne, Saint-Etienne, France
| | - N Klopp
- CHU d'Amiens, Amiens, France
| | | | | | | | | | | | | | - F Merklen
- Service ORL, CHU de Montpellier, Montpellier, France
| | | | - T Mom
- CHU de Clermont-Ferrand, Clermont-Ferrand, France
| | | | - I Mosnier
- Hôpital Pitié-Salpétrière, Paris, France
| | | | | | - P Piller
- CH de Nouméa, Nouméa, Nouvelle-Calédonie
| | - C Poncet
- Hôpital Rothschild, Paris, France
| | - E Radafy
- CH du Lamentin, Martinique, France
| | - S Roman
- CHU de Marseille, Marseille, France
| | | | | | | | - E Truy
- CHU de Lyon, Lyon, France
| | | | - A Uziel
- Service ORL, CHU de Montpellier, Montpellier, France.
| |
Collapse
|
44
|
Mosnier I, Ferrary E, Aubry K, Bordure P, Bozorg-Grayeli A, Deguine O, Eyermann C, Franco-Vidal V, Godey B, Guevara N, Karkas A, Klopp N, Labrousse M, Lebreton JP, Lerosey Y, Lescanne E, Loundon N, Marianowski R, Merklen F, Mezouaghi K, Mom T, Moreau S, Noël-Petroff N, Parietti-Winkler C, Piller P, Poncet C, Radafy E, Roman S, Roux-Vaillard S, Schmerber S, Tavernier L, Truy E, Vincent C, Sterkers O. The French National Cochlear Implant Registry (EPIIC): Cochlear implantation in adults over 65years old. Eur Ann Otorhinolaryngol Head Neck Dis 2020; 137 Suppl 1:S19-S25. [PMID: 32773333 DOI: 10.1016/j.anorl.2020.07.011] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
OBJECTIVES To analyze the performance of cochlear implants in French patients aged 65 and over, implanted between 2012 and 2016, using data from the French national registry for cochlear implants (EPIIC). MATERIALS AND METHODS The French national registry incorporates patient data from before implantation and for three years after implantation, stratified in different age groups (18-39, 40-64years, 65-74years and>75years). Here, we assessed the latter two categories. Hearing was assessed using mono- and disyllabic words in a silent background. The Category of Auditory Performance (CAP) scale was also implemented and subjects took the Abbreviated Profile of Hearing Aid Benefit (Aphab) questionnaire. RESULTS The population aged over 65 accounted for 38% (n=1193) of the 3178 adult implanted patients. The performance for mono- and disyllabic words in silence, the CAP scores and the APHAB questionnaire answers for ease of communication, background noise and reverberation were dramatically improved at one year post-implantation (P<0.0001 for each score) and remained stable between one and three years thereafter. The percentage improvement was similar across all age groups. The scores for loud-noise intolerance did not change after cochlear implantation in any age group. CONCLUSION Cochlear implants improve hearing and communication in subjects aged 65 and over, with comparable efficiency to that achieved in younger subjects. Cochlear implantation should thus be proposed whenever hearing aids provide only limited benefit. However, between 2012 and 2016, cochlear implantation was given to less than 1% of the French population aged 65 and over with profound deafness.
Collapse
Affiliation(s)
- I Mosnier
- AP-HP Sorbonne Université, Groupe hospitalier Pitié-Salpêtrière, Unité Fonctionnelle Implants auditifs et explorations fonctionnelles, Service ORL, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France.
| | - E Ferrary
- AP-HP Sorbonne Université, Groupe hospitalier Pitié-Salpêtrière, Unité Fonctionnelle Implants auditifs et explorations fonctionnelles, Service ORL, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France
| | - K Aubry
- CHU de Limoges, Limoges, France
| | | | | | | | | | | | - B Godey
- CHU de Rennes, Rennes, France
| | | | - A Karkas
- CHU de Saint-Étienne, Saint-Étienne, France
| | - N Klopp
- CHU d'Amiens, Amiens, France
| | | | | | | | | | | | | | - F Merklen
- CHU de Montpellier, Montpellier, France
| | | | - T Mom
- CHU de Clermont-Ferrand, Clermont-Ferrand, France
| | | | | | | | - P Piller
- CH de Nouméa, Nouméa, Nouvelle-Calédonie
| | - C Poncet
- Hôpital Rothschild, Paris, France
| | - E Radafy
- CH du Lamentin, Martinique, Guadeloupe
| | - S Roman
- CHU de Marseille, Marseille, France
| | | | | | | | - E Truy
- CHU de Lyon, Lyon, France
| | | | - O Sterkers
- AP-HP Sorbonne Université, Groupe hospitalier Pitié-Salpêtrière, Unité Fonctionnelle Implants auditifs et explorations fonctionnelles, Service ORL, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France
| |
Collapse
|
45
|
Loos E, Verhaert N, Darrouzet V, Godey B, Linder T, Vincent C, Lavieille JP, Schmerber S, Lescanne E, Trabalzini F, De Foer B, Van Havenbergh T, Somers T. Intratemporal facial nerve schwannomas: multicenter experience of 80 cases. Eur Arch Otorhinolaryngol 2020; 277:2209-2217. [PMID: 32279104 DOI: 10.1007/s00405-020-05960-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2020] [Accepted: 04/01/2020] [Indexed: 11/26/2022]
Abstract
PURPOSE To provide more data on the clinical presentation and natural evolution of facial nerve schwannomas and to provide guidance for therapeutic decision making. METHODS A retrospective case review of eighty patients diagnosed with a facial nerve schwannoma between 1990 and 2018 in ten tertiary referral centers in Europe was performed. Patients' demographics, symptomatology, audiometry, anatomical site (segments involved), size and whenever possible volume measurement were registered. RESULTS At presentation, transient or persistent facial palsy was the most common symptom, followed by hearing loss. The schwannoma involved more than one segment in the majority of the patients with the geniculate ganglion being most commonly involved. Initial treatment consisted of a wait and scan approach in 67.5%, surgery in 30% and radiation therapy in 2.5% of the patients. Tympanic segment schwannomas caused mainly conductive hearing loss and were more prone to develop facial palsy at follow-up. Internal auditory canal or cerebellopontine angle schwannomas presented with significantly more sensorineural hearing loss. CONCLUSIONS Although modern imaging has improved diagnosis of this tumor, choosing the best treatment modality remains a real challenge. Based on the literature review and current findings, more insights into the clinical course and the management of facial nerve schwannomas are provided.
Collapse
Affiliation(s)
- Elke Loos
- Department of ENT-HNS, European Institute for Otorhinolaryngology-Head and Neck Surgery and Skull Base Surgery, Sint Augustinus Hospital, GZA, Oosterveldlaan 24, 2600, Antwerp, Belgium
- Department of Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium
| | - Nicolas Verhaert
- Department of Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium
| | - Vincent Darrouzet
- Department of Otolaryngology, Skull Base Surgery, CHU de Bordeaux, Université de Bordeaux, 33000, Bordeaux, France
| | - Benoit Godey
- Department of ENT-HNS, University Hospital of Rennes, Rennes, France
| | - Thomas Linder
- Department of ENT-HNS, Cantonal Hospital Luzern, Luzern, Switzerland
| | - Christophe Vincent
- CHU Lille, Otologie et Otoneurologie, Université de Lille, Inserm U1008, Controlled Drug Delivery Systems and Biomaterials, Lille, France
| | - Jean Pierre Lavieille
- APHM, Hôpital de La Conception, Service d'oto-rhino-laryngologie et de chirurgie cervico-faciale, 147 Boulevard Baille, 13005, Marseille, France
| | | | - Emmanuel Lescanne
- Department of ENT, Head and Neck Surgery, Regional Hospital University Centre of Tours, 2, Boulevard Tonnellé, 37044, Tours Cedex 9, France
| | - Franco Trabalzini
- Department of ENT-HNS, Azienda Ospedaliero Universitaria Meyer, Firenze, Italy
| | - Bert De Foer
- Department of Radiology, Sint Augustinus Hospital, GZA, Oosterveldlaan 24, 2610, Antwerp, Belgium
| | | | - Thomas Somers
- Department of ENT-HNS, European Institute for Otorhinolaryngology-Head and Neck Surgery and Skull Base Surgery, Sint Augustinus Hospital, GZA, Oosterveldlaan 24, 2600, Antwerp, Belgium.
| |
Collapse
|
46
|
Fieux M, Franco-Vidal V, Devic P, Bricaire F, Charpiot A, Darrouzet V, Denoix L, Gatignol P, Guevara N, Montava M, Roch JA, Tankéré F, Tronche S, Veillon F, Vergez S, Vincent C, Lamas G, Tringali S. French Society of ENT (SFORL) guidelines. Management of acute Bell's palsy. Eur Ann Otorhinolaryngol Head Neck Dis 2020; 137:483-488. [PMID: 32636146 DOI: 10.1016/j.anorl.2020.06.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
AQFThe authors present the guidelines of the French Society of ENT and Head and Neck Surgery (SFORL) regarding the management of Bell's palsy in adults. After a literature review by a multidisciplinary workgroup, guidelines were drawn up based on retrieved articles and group-members' experience, then read over by an independent group to edit the final version. Guidelines were graded A, B, C or "expert opinion" according to decreasing level of evidence. Thorough ENT and neurological clinical examination is recommended in all patients presenting with peripheral facial palsy to confirm diagnosis of Bell's palsy. MRI with gadolinium enhancement should explore the entire course of the facial nerve, if possible within the first month. ENMG should be performed to assess prognosis for recovery. In confirmed Bell's palsy, corticosteroid therapy should be implemented as early as possible (ideally within 72h) at a dose of 1mg/kg/day for 7-10 days. Antiviral therapy should be associated to steroids in patients with severe and early-onset disease and in Ramsay-Hunt syndrome. Isolated antiviral therapy is not recommended. To date, there is no evidence that surgical facial nerve decompression provides benefit.
Collapse
Affiliation(s)
- M Fieux
- Service d'Otologie et d'Otoneurologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Chemin du Grand Revoyet, 69495 Pierre-Bénite, France
| | - V Franco-Vidal
- Service ORL et Chirurgie Cervico-Faciale, Hôpital Pellegrin, Place Amélie Raba-Léon, 33076 Bordeaux, France
| | - P Devic
- Service de Neurologie Clinique et Fonctionnelle, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Chemin du Grand Revoyet, 69495 Pierre-Bénite, France
| | - F Bricaire
- Service des Maladies Infectieuses, Hôpital Pitié-Salpêtrière, AP-HP, 47-83, Boulevard de l'Hôpital, 75013 Paris, France
| | - A Charpiot
- Service ORL et Chirurgie Cervico-Faciale, Hôpital de Hautepierre, 1, Avenue de Molière, 67200 Strasbourg, France
| | - V Darrouzet
- Service ORL et Chirurgie Cervico-Faciale, Hôpital Pellegrin, Place Amélie Raba-Léon, 33076 Bordeaux, France
| | - L Denoix
- Service d'Otologie et d'Otoneurologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Chemin du Grand Revoyet, 69495 Pierre-Bénite, France
| | - P Gatignol
- Service ORL et Chirurgie Cervico-Faciale, Hôpital Pitié-Salpêtrière, AP-HP, 47-83 Boulevard de l'Hôpital, 75013 Paris, France
| | - N Guevara
- Service ORL et Chirurgie Cervico-Faciale, Centre Hospitalier de Nice, IUFC, 31, Avenue de Valombrose, 01600 Nice, France
| | - M Montava
- Service ORL et Chirurgie Cervico-Faciale, Hôpital de la Conception, AP-HM, 147, Boulevard Baille, 13005 Marseille, France
| | - J A Roch
- Service de Radiologie, Hôpital Privé Jean Mermoz, 55, Avenue Jean Mermoz, 69008 Lyon, France
| | - F Tankéré
- Service ORL et Chirurgie Cervico-Faciale, Hôpital Pitié-Salpêtrière, AP-HP, 47-83 Boulevard de l'Hôpital, 75013 Paris, France
| | - S Tronche
- SFORL, 26, Rue Lalo, 75016 Paris, France
| | - F Veillon
- Service de Radiologie, Hôpital de Hautepierre, 1, Avenue de Molière, 67200 Strasbourg, France
| | - S Vergez
- Service ORL et Chirurgie Cervico-Faciale, Hôpital Larrey, 24, Chemin de Pouvourville, 31059 Toulouse, France
| | - C Vincent
- Service ORL et Chirurgie Cervico-Faciale, Hôpital Salengro, Rue Michel Polonowski, 59037 Lille, France
| | - G Lamas
- Service ORL et Chirurgie Cervico-Faciale, Hôpital Pitié-Salpêtrière, AP-HP, 47-83 Boulevard de l'Hôpital, 75013 Paris, France
| | - S Tringali
- Service d'Otologie et d'Otoneurologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Chemin du Grand Revoyet, 69495 Pierre-Bénite, France.
| |
Collapse
|
47
|
Dubrulle F, Chaton V, Risoud M, Farah H, Charley Q, Vincent C. The round window sign: a sensitive sign to detect perilymphatic fistulae on delayed postcontrast 3D-FLAIR sequence. Eur Radiol 2020; 30:6303-6310. [PMID: 32468106 DOI: 10.1007/s00330-020-06924-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2019] [Revised: 03/31/2020] [Accepted: 04/28/2020] [Indexed: 11/25/2022]
Abstract
OBJECTIVES The aim of this study is to assess the diagnostic performance of a new MR sign, named the round window sign (RWS), to diagnose perilymphatic fistula (PLF) in a population of patients with chronic cochleo-vestibular symptoms, classified as definite or probable Menière's disease (MD). METHODS A total of 164 patients (mean age 52 ± 35 years) with chronic cochleo-vestibular symptoms underwent MRI, between 4 and 5 h after intravenous gadoteric acid injection (Dotarem®, 0.1 mmol/kg). MRI exploration was carried out on a 3-T Achieva® TX scanner. We analyzed the presence of the RWS, defined as a nodular FLAIR high signal in the round window (RW) and the presence of associated saccular hydrops. When this RWS was present, a temporal bone CT scan was performed and the RW was analyzed. RESULTS Of the 164 patients with definite MD (85 patients) or probable MD (79 patients), we found the RWS in 18 (11%), and 17/18 were classified into the group of probable MD. All these 18 patients showed other MR sequences considered as normal, including heavily weighted T2 imaging. Among these 18 patients, the temporal bone CT examination presented a filling of the RW in 13 patients (72%) and no filling of the RW in 5 patients (28%). Seven patients were surgically managed confirming in vivo the PLF diagnosis. The RWS was associated with the presence of a saccular hydrops in 4 cases. CONCLUSION Delayed postcontrast 3D-FLAIR may reveal perilymphatic fistulae in patients with probable Menière's disease using the round window sign. KEY POINTS • MRI with delayed acquisition can detect perilymphatic fistulae with perfect sensitivity, based on the presence of the round window sign. • This visual sign is only visible on a 3D-FLAIR sequence. • 3D-FLAIR sequence with delayed acquisition is more sensitive than temporal bone CT scan examination in detecting PLF.
Collapse
Affiliation(s)
- Frédérique Dubrulle
- Imaging Department, Head and Neck Unit, Huriez Hospital, CHU Lille, 59037, Lille, France.
| | - Victor Chaton
- Imaging Department, Head and Neck Unit, Huriez Hospital, CHU Lille, 59037, Lille, France
| | - Michael Risoud
- Otology and Oto-neurosurgery Department, Salengro Hospital, CHU Lille, 59037, Lille, France
| | - Hedi Farah
- Imaging Department, Head and Neck Unit, Huriez Hospital, CHU Lille, 59037, Lille, France
| | - Quentin Charley
- Otology and Oto-neurosurgery Department, Salengro Hospital, CHU Lille, 59037, Lille, France
| | - Christophe Vincent
- Otology and Oto-neurosurgery Department, Salengro Hospital, CHU Lille, 59037, Lille, France
| |
Collapse
|
48
|
Risoud M, Tardivel M, Lemesre PE, Bonne NX, Vincent C. Optimised immunofluorescence method on cleared intact Mongolian gerbil cochlea. Eur Ann Otorhinolaryngol Head Neck Dis 2020; 137:145-150. [PMID: 32085983 DOI: 10.1016/j.anorl.2020.01.015] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Immunofluorescence on cleared intact cochlea allows detailed analysis of the cochlear ultrastructure, while avoiding the problems of dissection and serial sections. Protocols have been developed for mice and Mongolian gerbils. This technical note proposes a detailed and optimised immunofluorescence protocol in the Mongolian gerbil comprising significant quantitative and qualitative improvements. This protocol sequentially comprises: fixation (1 day), decalcification (6 days), pre-treatment (7.5hours), immunolabelling (42hours), dehydration and clearing (23hours), followed by mounting and laser scanning confocal microscopy acquisition. This protocol has been optimised in terms of duration (10 days versus 13 days) with a reduction of the number of steps, improvement of the specificity of immunolabelling and optimisation of the quality of the results obtained. This technical note provides a detailed description of this protocol.
Collapse
Affiliation(s)
- M Risoud
- CHU de Lille, Department of Otology and Neurotology, 59000, Lille, France; Université de Lille, CHU de Lille, INSERM U1008 - Controlled Drug Delivery Systems and Biomaterials, 59000 Lille, France.
| | - M Tardivel
- Université de Lille, BioImaging Centre Lille-Nord de France (BICeL), 59000, Lille, France
| | - P-E Lemesre
- CHU de Lille, Department of Otology and Neurotology, 59000, Lille, France; Université de Lille, CHU de Lille, INSERM U1008 - Controlled Drug Delivery Systems and Biomaterials, 59000 Lille, France
| | - N-X Bonne
- CHU de Lille, Department of Otology and Neurotology, 59000, Lille, France; Université de Lille, CHU de Lille, INSERM U1192 - Proteomics Inflammatory Response Mass Spectrometry (PRISM), 59000 Lille, France
| | - C Vincent
- CHU de Lille, Department of Otology and Neurotology, 59000, Lille, France; Université de Lille, CHU de Lille, INSERM U1008 - Controlled Drug Delivery Systems and Biomaterials, 59000 Lille, France
| |
Collapse
|
49
|
Laccourreye O, Lisan Q, Bonfils P, Garrel R, Jankowski R, Karkas A, Leboulanger N, Makeieff M, Righini C, Vincent C, Martin C. Use of P-values and the terms "significant", "non-significant" and "suggestive" in Abstracts in the European Annals of Otorhinolaryngology, Head & Neck Diseases. Eur Ann Otorhinolaryngol Head Neck Dis 2019; 136:469-473. [PMID: 31699624 DOI: 10.1016/j.anorl.2019.10.008] [Citation(s) in RCA: 82] [Impact Index Per Article: 16.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
OBJECTIVES To evaluate the use of P-values and the terms "significant", "non-significant" and "suggestive" in Abstracts in the European Annals of Otorhinolaryngology, Head & Neck Diseases. MATERIALS AND METHODS Consecutive articles accepted for publication during the period January 2016 - February 2019 were systematically reviewed. Main goal: descriptive analysis of the citation of P-values and use of the terms "significant", "non-significant" and "suggestive" in Abstracts. Secondary goal: analytic study of: (i) correlations between citation of a P-value and the main characteristics of authors and topics; and (ii) misuse of the terms "significant", "non-significant" and "suggestive" with respect to cited P-values, and correlations with author and topic characteristics. RESULTS In all, 91 articles were included. P-values and the terms "significant", "non-significant" and "suggestive" were cited in 35.1%, 41.7%, 10.9% and 0% of Abstracts, respectively. Citing a P-value did not significantly correlate with author or topic characteristics. There were discrepancies between the terms "non-significant", "significant" and "suggestive" and P-values given in the body of the article in 57.1% of Abstracts, with 30.7% overestimation and 25.2% underestimation of results, without significant correlation with author or topic characteristics. CONCLUSION Authors, editors and reviewers must pay particular attention to the spin resulting from inappropriate use of the terms "significant", "non-significant" and "suggestive" in Abstracts of articles submitted to the European Annals of Otorhinolaryngology, Head & Neck Diseases, to improve the rigor, quality and value of the scientific message delivered to the reader.
Collapse
Affiliation(s)
- O Laccourreye
- Comité de rédaction, annales d'otorhinolaryngologie et de pathologie cervico-faciale, Elsevier ed., 92130 Issy-les-Moulineaux, France; Université Paris Descartes Sorbonne Paris Cité, 75006 Paris, France.
| | - Q Lisan
- Comité de rédaction, annales d'otorhinolaryngologie et de pathologie cervico-faciale, Elsevier ed., 92130 Issy-les-Moulineaux, France; Université Paris Descartes Sorbonne Paris Cité, 75006 Paris, France
| | - P Bonfils
- Comité de rédaction, annales d'otorhinolaryngologie et de pathologie cervico-faciale, Elsevier ed., 92130 Issy-les-Moulineaux, France; Université Paris Descartes Sorbonne Paris Cité, 75006 Paris, France
| | - R Garrel
- Comité de rédaction, annales d'otorhinolaryngologie et de pathologie cervico-faciale, Elsevier ed., 92130 Issy-les-Moulineaux, France; Université de Montpellier, 34090 Montpellier, France
| | - R Jankowski
- Comité de rédaction, annales d'otorhinolaryngologie et de pathologie cervico-faciale, Elsevier ed., 92130 Issy-les-Moulineaux, France; Université de Lorraine, 54505 Nancy, France
| | - A Karkas
- Comité de rédaction, annales d'otorhinolaryngologie et de pathologie cervico-faciale, Elsevier ed., 92130 Issy-les-Moulineaux, France; Université de Saint-Étienne, 42270 Saint-Étienne, France
| | - N Leboulanger
- Comité de rédaction, annales d'otorhinolaryngologie et de pathologie cervico-faciale, Elsevier ed., 92130 Issy-les-Moulineaux, France; Université Paris Descartes Sorbonne Paris Cité, 75006 Paris, France
| | - M Makeieff
- Comité de rédaction, annales d'otorhinolaryngologie et de pathologie cervico-faciale, Elsevier ed., 92130 Issy-les-Moulineaux, France; Université de Reims, 51100 Reims, France
| | - C Righini
- Comité de rédaction, annales d'otorhinolaryngologie et de pathologie cervico-faciale, Elsevier ed., 92130 Issy-les-Moulineaux, France; Université de Grenoble, 38700 Grenoble, France
| | - C Vincent
- Comité de rédaction, annales d'otorhinolaryngologie et de pathologie cervico-faciale, Elsevier ed., 92130 Issy-les-Moulineaux, France; Université de Lille, 59120 Lille, France
| | - C Martin
- Comité de rédaction, annales d'otorhinolaryngologie et de pathologie cervico-faciale, Elsevier ed., 92130 Issy-les-Moulineaux, France
| |
Collapse
|
50
|
Bonne N, Hanson J, Gauvrit F, Risoud M, Vincent C. Long‐term evaluation of sound localisation in single‐sided deaf adults fitted with a BAHA device. Clin Otolaryngol 2019; 44:898-904. [DOI: 10.1111/coa.13381] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2017] [Revised: 05/02/2019] [Accepted: 05/20/2019] [Indexed: 11/28/2022]
Affiliation(s)
| | | | - Fanny Gauvrit
- Service d'Otologie et d'OtoneurologieCHU de Lille Lille France
| | - Michaël Risoud
- Service d'Otologie et d'OtoneurologieCHU de Lille Lille France
| | | |
Collapse
|